{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:26:18Z","timestamp":1793395578829,"version":"4.5.0"},"reference-count":473,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Japanese Society for Cancer of the Colon and Rectum"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Approximately 5% of all colorectal cancers have a strong genetic component and are classified as hereditary colorectal cancer (HCRC). Some of the unique features commonly seen in HCRC cases include early age of onset, synchronous\/metachronous cancer occurrence, and multiple cancers in other organs. These characteristics require different management approaches, including diagnosis, treatment or surveillance, from those used in the management of sporadic colorectal cancer. Accurate diagnosis of HCRC is essential because it enables targeted surveillance and risk reduction strategies that improve patient outcomes. Recent genetic advances revealed several causative genes for polyposis and non-polyposis syndromes. The Japanese Society for Cancer of the Colon and Rectum (JSCCR) first published guidelines for the management of HCRC in 2012, with subsequent revisions every 4\u00a0years. The 2024 update to the JSCCR guidelines for HCRC was developed by meticulously reviewing evidence from systematic reviews and the consensus of the JSCCR HCRC Guidelines Committee, which includes representatives from patient advocacy groups for FAP and Lynch syndrome. These guidelines provide an up-to-date summary of HCRC, along with clinical recommendations for managing FAP and Lynch syndrome.<\/jats:p>","DOI":"10.1007\/s10147-025-02892-1","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T18:29:58Z","timestamp":1762799398000},"page":"1-66","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2024 for the clinical practice of hereditary colorectal cancer"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8901-6911","authenticated-orcid":false,"given":"Kohji","family":"Tanakaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Kumamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuki","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ishimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Komine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunitoshi","family":"Shigeyasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusaku","family":"Shimamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Shimodaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinari","family":"Takao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misato","family":"Takao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Takamizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Chino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hourin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiko","family":"Nakamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Hasumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji","family":"Banno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Hinoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Fujiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Horimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Miguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Mizuuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Miyakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Mutoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Sakamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Itabashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Ajioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Japanese Society for Cancer of the Colon, Rectum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"2892_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1159\/000529799","volume":"104","author":"H Yamamoto","year":"2023","unstructured":"Yamamoto H, Sakamoto H, Kumagai H et al (2023) Clinical guidelines for diagnosis and management of Peutz-Jeghers syndrome in children and adults. Digestion 104:335\u2013347. https:\/\/doi.org\/10.1159\/000529799","journal-title":"Digestion"},{"key":"2892_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.23922\/jarc.2023-002","volume":"7","author":"T Matsumoto","year":"2023","unstructured":"Matsumoto T, Umeno J, Jimbo K et al (2023) Clinical guidelines for diagnosis and management of juvenile polyposis syndrome in children and adults - Secondary publication. J Anus Rectum Colon 7:115\u2013125. https:\/\/doi.org\/10.23922\/jarc.2023-002","journal-title":"J Anus Rectum Colon"},{"key":"2892_CR3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.23922\/jarc.2023-028","volume":"7","author":"T Takayama","year":"2023","unstructured":"Takayama T, Muguruma N, Igarashi M et al (2023) Clinical guidelines for diagnosis and management of Cowden syndrome\/PTEN hamartoma tumor syndrome in children and adults - secondary publication. J Anus Rectum Colon 7:284\u2013300. https:\/\/doi.org\/10.23922\/jarc.2023-028","journal-title":"J Anus Rectum Colon"},{"key":"2892_CR4","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1053\/j.gastro.2013.10.045","volume":"146","author":"MK Gala","year":"2014","unstructured":"Gala MK, Mizukami Y, Le LP et al (2014) Germline mutations in oncogene-induced senescence pathways are associated with multiple sessile serrated adenomas. Gastroenterology 146:520\u2013529","journal-title":"Gastroenterology"},{"key":"2892_CR5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ng.2263","volume":"44","author":"E Jaeger","year":"2012","unstructured":"Jaeger E, Leedham S, Lewis A et al (2012) Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat Genet 44:699\u2013703. https:\/\/doi.org\/10.1038\/ng.2263","journal-title":"Nat Genet"},{"key":"2892_CR6","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1053\/j.gastro.2008.12.076","volume":"136","author":"D Buchanan","year":"2009","unstructured":"Buchanan D, Young J (2009) A perspective on biallelic MUTYH mutations in patients with hyperplastic polyposis syndrome. Gastroenterology 136:2407\u20132408","journal-title":"Gastroenterology"},{"key":"2892_CR7","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1200\/JCO.2016.71.0012","volume":"35","author":"MB Yurgelun","year":"2017","unstructured":"Yurgelun MB, Kulke MH, Fuchs CS et al (2017) Cancer susceptibility gene mutations in individuals with colorectal cancer. J Clin Oncol 35:1086\u20131095. https:\/\/doi.org\/10.1200\/JCO.2016.71.0012","journal-title":"J Clin Oncol"},{"key":"2892_CR8","doi-asserted-by":"publisher","first-page":"e508","DOI":"10.1016\/j.cgh.2021.04.013","volume":"20","author":"PLS Uson Jr","year":"2022","unstructured":"Uson PLS Jr, Riegert-Johnson D, Boardman L et al (2022) Germline cancer susceptibility gene testing in unselected patients with colorectal adenocarcinoma: A multicenter prospective study. Clin Gastroenterol Hepatol 20:e508\u2013e528","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2892_CR9","unstructured":"National Comprehensive Cancer Network (2023) NCCN Clinical Practice Guidelines in Oncology: Genetic\/Familial High-Risk Assessment: Colorectal. Version 2. Available from https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=2&id=1436"},{"key":"2892_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/gutjnl-2015-309675","volume":"66","author":"P M\u00f8ller","year":"2017","unstructured":"M\u00f8ller P, Sepp\u00e4l\u00e4 T, Bernstein I et al (2017) Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut 66:464\u2013472","journal-title":"Gut"},{"key":"2892_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195572","volume":"13","author":"C Saita","year":"2018","unstructured":"Saita C, Yamaguchi T, Horiguchi SI et al (2018) Tumor development in Japanese patients with Lynch syndrome. PLoS ONE 13:e0195572. https:\/\/doi.org\/10.1371\/journal.pone.0195572","journal-title":"PLoS ONE"},{"key":"2892_CR12","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson Jr","year":"1971","unstructured":"Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68:820\u2013823","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2892_CR13","unstructured":"Japanese Association of Medical Sciences (2011) Guidelines for genetic tests and diagnoses in medical practice. Avialable from https:\/\/jams.med.or.jp\/guideline\/index.html"},{"key":"2892_CR14","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1002\/cam4.2432","volume":"8","author":"Y Kiyozumi","year":"2019","unstructured":"Kiyozumi Y, Matsubayashi H, Horiuchi Y et al (2019) Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients. Cancer Med 8:5534\u20135543. https:\/\/doi.org\/10.1002\/cam4.2432","journal-title":"Cancer Med"},{"key":"2892_CR15","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1111\/j.1463-1318.2010.02345.x","volume":"13","author":"A Sinha","year":"2011","unstructured":"Sinha A, Tekkis PP, Gibbons DC et al (2011) Risk factors predicting desmoid occurrence in patients with familial adenomatous polyposis: a meta-analysis. Colorectal Dis 13:1222\u20131229. https:\/\/doi.org\/10.1111\/j.1463-1318.2010.02345.x","journal-title":"Colorectal Dis"},{"key":"2892_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10689-018-0085-3","volume":"18","author":"J Chenbhanich","year":"2019","unstructured":"Chenbhanich J, Atsawarungruangkit A, Korpaisarn S et al (2019) Prevalence of thyroid diseases in familial adenomatous polyposis: a systematic review and meta-analysis. Fam Cancer 18:53\u201362","journal-title":"Fam Cancer"},{"issue":"8","key":"2892_CR17","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/gim.2015.166","volume":"18","author":"LR Susswein","year":"2016","unstructured":"Susswein LR, Marshall ML, Nusbaum R et al (2016) Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. Genet Med 18(8):823\u2013832","journal-title":"Genet Med"},{"key":"2892_CR18","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1053\/j.gastro.2015.05.006","volume":"149","author":"MB Yurgelun","year":"2015","unstructured":"Yurgelun MB, Allen B, Kaldate RR et al (2015) Identification of a variety of mutations in cancer predisposition genes in patients with suspected Lynch syndrome. Gastroenterology 149:604-613.e20","journal-title":"Gastroenterology"},{"key":"2892_CR19","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1053\/j.gastro.2017.11.004","volume":"154","author":"EM Stoffel","year":"2018","unstructured":"Stoffel EM, Koeppe E, Everett J et al (2018) Germline genetic features of young individuals with colorectal cancer. Gastroenterology 154:897\u2013905","journal-title":"Gastroenterology"},{"key":"2892_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10897-013-9649-4","volume":"23","author":"W Eijzenga","year":"2014","unstructured":"Eijzenga W, Hahn DE, Aaronson NK et al (2014) Specific psychosocial issues of individuals undergoing genetic counseling for cancer-a literature review. J Genet Couns 23:133\u2013146. https:\/\/doi.org\/10.1007\/s10897-013-9649-4","journal-title":"J Genet Couns"},{"key":"2892_CR21","unstructured":"Yen T, Stanich PP, Axell L, et al. (1998): APC-associated polyposis conditions. GeneReviews\u00ae. Seattle(WA: University of Washington, Seattle; 1993\u20132024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1345"},{"key":"2892_CR22","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1126\/science.275.5307.1787","volume":"275","author":"PJ Morin","year":"1997","unstructured":"Morin PJ, Sparks AB, Korinek V et al (1997) Activation of \u03b2-catenin-Tcf signaling in colon cancer by mutation in \u03b2-catenin or APC. Science 275:1787\u20131790","journal-title":"Science"},{"key":"2892_CR23","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1126\/science.280.5363.596","volume":"280","author":"J Behrens","year":"1998","unstructured":"Behrens J, Jerchow BA, Wurtele M et al (1998) Functional interaction of an axin homolog, conductin, with \u03b2-catenin, APC, and GSK3\u03b2. Science 280:596\u2013599","journal-title":"Science"},{"key":"2892_CR24","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1002\/ijc.23390","volume":"122","author":"M Miyaki","year":"2008","unstructured":"Miyaki M, Yamaguchi T, Iijima T et al (2008) Difference in characteristics of APC mutations between colonic and extracolonic tumors of FAP patients: variations with phenotype. Int J Cancer 122:2491\u20132497. https:\/\/doi.org\/10.1002\/ijc.23390","journal-title":"Int J Cancer"},{"key":"2892_CR25","first-page":"4055","volume":"52","author":"H Nagase","year":"1992","unstructured":"Nagase H, Miyoshi Y, Horii A et al (1992) Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res 52:4055\u20134057","journal-title":"Cancer Res"},{"key":"2892_CR26","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1136\/gut.35.11.1622","volume":"35","author":"KP Nugent","year":"1994","unstructured":"Nugent KP, Phillips RK, Hodgson SV et al (1994) Phenotypic expression in familial adenomatous polyposis: partial prediction by mutation analysis. Gut 35:1622\u20131623","journal-title":"Gut"},{"key":"2892_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1023\/A:1023286520725","volume":"2","author":"AL Knudsen","year":"2003","unstructured":"Knudsen AL, Bisgaard ML, B\u00fclow S (2003) Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer 2:43\u201355","journal-title":"Fam Cancer"},{"key":"2892_CR28","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s00595-016-1398-1","volume":"47","author":"H Kobayashi","year":"2017","unstructured":"Kobayashi H, Ishida H, Ueno H et al (2017) Association between the age and the development of colorectal cancer in patients with familial adenomatous polyposis: a multi-institutional study. Surg Today 47:470\u2013475","journal-title":"Surg Today"},{"key":"2892_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/BF01871370","volume":"26","author":"M Murata","year":"1981","unstructured":"Murata M, Utsunomiya J, Iwama T et al (1981) Frequency of adenomatosis coli in Japan. Jinrui Idengaku Zasshi 26:19\u201330","journal-title":"Jinrui Idengaku Zasshi"},{"key":"2892_CR30","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/gut.2007.136127","volume":"57","author":"HF Vasen","year":"2008","unstructured":"Vasen HF, M\u00f6slein G, Alonso A et al (2008) Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57:704\u2013713","journal-title":"Gut"},{"key":"2892_CR31","volume-title":"Familial polyposis coli. Gastrointestinal Tract Cancer","author":"HJR Bussey","year":"1978","unstructured":"Bussey HJR, Morson BC (1978) Familial polyposis coli. Gastrointestinal Tract Cancer. Springer, Boston"},{"key":"2892_CR32","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10147-004-0414-4","volume":"9","author":"T Iwama","year":"2004","unstructured":"Iwama T, Tamura K, Morita T et al (2004) A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan. Int J Clin Oncol 9:308\u2013316","journal-title":"Int J Clin Oncol"},{"key":"2892_CR33","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1001\/jama.2012.8780","volume":"308","author":"S Grover","year":"2012","unstructured":"Grover S, Kastrinos F, Steyerberg EW et al (2012) Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. JAMA 308:485\u2013492","journal-title":"JAMA"},{"key":"2892_CR34","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1056\/NEJM199503303321302","volume":"332","author":"SR Hamilton","year":"1995","unstructured":"Hamilton SR, Liu B, Parsons RE et al (1995) The molecular basis of Turcot\u02bcs syndrome. N Engl J Med 332:839\u2013847","journal-title":"N Engl J Med"},{"key":"2892_CR35","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s10147-021-01946-4","volume":"26","author":"M Takao","year":"2021","unstructured":"Takao M, Yamaguchi T, Eguchi H et al (2021) APC germline variant analysis in the adenomatous polyposis phenotype in Japanese patients. Int J Clin Oncol 26:1661\u20131670","journal-title":"Int J Clin Oncol"},{"key":"2892_CR36","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/humu.20549","volume":"28","author":"S Aretz","year":"2007","unstructured":"Aretz S, Stienen D, Friedrichs N et al (2007) Somatic APC mosaicism: a frequent cause of familial adenomatous polyposis (FAP). Hum Mutat 28:985\u2013992. https:\/\/doi.org\/10.1002\/humu.20549","journal-title":"Hum Mutat"},{"key":"2892_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/gut.2006.117796","volume":"57","author":"FJ Hes","year":"2008","unstructured":"Hes FJ, Nielsen M, Bik EC et al (2008) Somatic APC mosaicism: an underestimated cause of polyposis coli. Gut 57:71\u201376","journal-title":"Gut"},{"key":"2892_CR38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12920-019-0553-0","volume":"12","author":"B Kim","year":"2019","unstructured":"Kim B, Won D, Jang M et al (2019) Next-generation sequencing with comprehensive bioinformatics analysis facilitates somatic mosaic APC gene mutation detection in patients with familial adenomatous polyposis. BMC Med Genomics 12:103. https:\/\/doi.org\/10.1186\/s12920-019-0553-0","journal-title":"BMC Med Genomics"},{"key":"2892_CR39","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1053\/j.gastro.2016.10.040","volume":"152","author":"AM Jansen","year":"2017","unstructured":"Jansen AM, Crobach S, Geurts-Giele WR et al (2017) Distinct patterns of somatic mosaicism in the APC gene in neoplasms from patients with unexplained adenomatous polyposis. Gastroenterology 152:546-549.e3","journal-title":"Gastroenterology"},{"key":"2892_CR40","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1136\/gutjnl-2011-300348","volume":"61","author":"DL Worthley","year":"2012","unstructured":"Worthley DL, Phillips KD, Wayte N et al (2012) Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome. Gut 61:774\u2013779","journal-title":"Gut"},{"key":"2892_CR41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.giec.2021.08.004","volume":"32","author":"W Kim","year":"2022","unstructured":"Kim W, Kidambi T, Lin J et al (2022) Genetic syndromes associated with gastric cancer. Gastrointest Endosc Clin N Am 32:147\u2013162. https:\/\/doi.org\/10.1016\/j.giec.2021.08.004","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"2892_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2021.101728","volume":"50","author":"I Tacheci","year":"2021","unstructured":"Tacheci I, Repak R, Podhola M et al (2021) Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS)-a helicobacter-opposite point. Best Pract Res Clin Gastroenterol 50:101728. https:\/\/doi.org\/10.1016\/j.bpg.2021.101728","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2892_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/ng828","volume":"30","author":"N Al-Tassan","year":"2002","unstructured":"Al-Tassan N, Chmiel NH, Maynard J et al (2002) Inherited variants of MYH associated with somatic G: C\u2013>T: A mutations in colorectal tumors. Nat Genet 30:227\u2013232","journal-title":"Nat Genet"},{"key":"2892_CR44","unstructured":"Nielsen M, Infante E, Brand R (2019) MUTYH Polyposis.: University of Washington, GeneReviews\u00ae. Seattle: University of Washington, Seattle; 1993\u20132024."},{"key":"2892_CR45","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1200\/JCO.2008.21.6853","volume":"27","author":"SJ Lubbe","year":"2009","unstructured":"Lubbe SJ, Di Bernardo MC, Chandler IP et al (2009) Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol 27:3975\u20133980. https:\/\/doi.org\/10.1200\/JCO.2008.21.6853","journal-title":"J Clin Oncol"},{"key":"2892_CR46","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10147-017-1234-7","volume":"23","author":"M Takao","year":"2018","unstructured":"Takao M, Yamaguchi T, Eguchi H et al (2018) Characteristics of MUTYH variants in Japanese colorectal polyposis patients. Int J Clin Oncol 23:497\u2013503","journal-title":"Int J Clin Oncol"},{"key":"2892_CR47","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1038\/sj.bjc.6605966","volume":"103","author":"E Theodoratou","year":"2010","unstructured":"Theodoratou E, Campbell H, Tenesa A et al (2010) A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. Br J Cancer 103:1875\u20131884","journal-title":"Br J Cancer"},{"key":"2892_CR48","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1053\/j.gastro.2014.01.022","volume":"146","author":"AK Win","year":"2014","unstructured":"Win AK, Dowty JG, Cleary SP et al (2014) Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology 146:1208-1211.e1-5","journal-title":"Gastroenterology"},{"key":"2892_CR49","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/gutjnl-2012-304121","volume":"63","author":"X Ma","year":"2014","unstructured":"Ma X, Zhang B, Zheng W (2014) Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Gut 63:326\u2013336","journal-title":"Gut"},{"key":"2892_CR50","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10689-021-00285-7","volume":"21","author":"AB Thompson","year":"2022","unstructured":"Thompson AB, Sutcliffe EG, Arvai K et al (2022) Monoallelic MUTYH pathogenic variants ascertained via multi-gene hereditary cancer panels are not associated with colorectal, endometrial, or breast cancer. Fam Cancer 21:415\u2013422","journal-title":"Fam Cancer"},{"key":"2892_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/10409230590935433","volume":"40","author":"P Garg","year":"2005","unstructured":"Garg P, Burgers PM (2005) DNA polymerases that propagate the eukaryotic DNA replication fork. Crit Rev Biochem Mol Biol 40:115\u2013128. https:\/\/doi.org\/10.1080\/10409230590935433","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"2892_CR52","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ng.2503","volume":"45","author":"C Palles","year":"2013","unstructured":"Palles C, Cazier JB, Howarth KM et al (2013) Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet 45:136\u2013144. https:\/\/doi.org\/10.1038\/ng.2503","journal-title":"Nat Genet"},{"key":"2892_CR53","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1038\/s41436-020-0922-2","volume":"22","author":"P Mur","year":"2020","unstructured":"Mur P, Garc\u00eda-Mulero S, Del Valle J et al (2020) Role of POLE and POLD1 in familial cancer. Genet Med 22:2089\u20132100","journal-title":"Genet Med"},{"key":"2892_CR54","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/gim.2015.75","volume":"18","author":"F Bellido","year":"2016","unstructured":"Bellido F, Pineda M, Aiza G et al (2016) POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and\/or polyposis: review of reported cases and recommendations for genetic testing and surveillance. Genet Med 18:325\u2013332","journal-title":"Genet Med"},{"key":"2892_CR55","doi-asserted-by":"publisher","first-page":"26732","DOI":"10.18632\/oncotarget.15810","volume":"8","author":"C Esteban-Jurado","year":"2017","unstructured":"Esteban-Jurado C, Gim\u00e9nez-Zaragoza D, Mu\u00f1oz J et al (2017) POLE and POLD1 screening in 155 patients with multiple polyps and early-onset colorectal cancer. Oncotarget 8:26732\u201326743. https:\/\/doi.org\/10.18632\/oncotarget.15810","journal-title":"Oncotarget"},{"key":"2892_CR56","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1093\/hmg\/ddu058","volume":"23","author":"L Valle","year":"2014","unstructured":"Valle L, Hern\u00e1ndez-Ill\u00e1n E, Bellido F et al (2014) New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis. Hum Mol Genet 23:3506\u20133512","journal-title":"Hum Mol Genet"},{"key":"2892_CR57","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/ejhg.2014.242","volume":"23","author":"FA Elsayed","year":"2015","unstructured":"Elsayed FA, Kets CM, Ruano D et al (2015) Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer. Eur J Hum Genet 23:1080\u20131084. https:\/\/doi.org\/10.1038\/ejhg.2014.242","journal-title":"Eur J Hum Genet"},{"key":"2892_CR58","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ijc.29396","volume":"137","author":"I Spier","year":"2015","unstructured":"Spier I, Holzapfel S, Altm\u00fcller J et al (2015) Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas. Int J Cancer 137:320\u2013331. https:\/\/doi.org\/10.1002\/ijc.29396","journal-title":"Int J Cancer"},{"key":"2892_CR59","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/gim.2017.185","volume":"20","author":"DD Buchanan","year":"2018","unstructured":"Buchanan DD, Stewart JR, Clendenning M et al (2018) Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1. Genet Med 20:890\u2013895","journal-title":"Genet Med"},{"key":"2892_CR60","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10689-015-9826-8","volume":"14","author":"LG Aoude","year":"2015","unstructured":"Aoude LG, Heitzer E, Johansson P et al (2015) POLE mutations in families predisposed to cutaneous melanoma. Fam Cancer 14:621\u2013628","journal-title":"Fam Cancer"},{"issue":"3","key":"2892_CR61","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10689-015-9803-2","volume":"14","author":"MF Hansen","year":"2015","unstructured":"Hansen MF, Johansen J, Bj\u00f8rnevoll I et al (2015) A novel POLE mutation associated with cancers of colon, pancreas, ovaries and small intestine. Fam Cancer 14(3):437\u2013448","journal-title":"Fam Cancer"},{"key":"2892_CR62","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3892\/ijo.2014.2410","volume":"45","author":"A Rohlin","year":"2014","unstructured":"Rohlin A, Zagoras T, Nilsson S et al (2014) A mutation in POLE predisposing to a multi-tumour phenotype. Int J Oncol 45:77\u201381. https:\/\/doi.org\/10.3892\/ijo.2014.2410","journal-title":"Int J Oncol"},{"key":"2892_CR63","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10689-021-00256-y","volume":"21","author":"C Palles","year":"2022","unstructured":"Palles C, Martin L, Domingo E et al (2022) The clinical features of polymerase proofreading associated polyposis (PPAP) and recommendations for patient management. Fam Cancer 21:197\u2013209","journal-title":"Fam Cancer"},{"key":"2892_CR64","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/jjco\/hyaa090","volume":"50","author":"T Ito","year":"2020","unstructured":"Ito T, Nomizu T, Eguchi H et al (2020) The first case report of polymerase proofreading-associated polyposis in POLD1 variant, c.1433G>A p. S478N, in Japan. Jpn J Clin Oncol 50:1080\u20131083. https:\/\/doi.org\/10.1093\/jjco\/hyaa090","journal-title":"Jpn J Clin Oncol"},{"key":"2892_CR65","first-page":"594","volume":"58","author":"M Ikeda","year":"1998","unstructured":"Ikeda M, Orimo H, Moriyama H et al (1998) Close correlation between mutations of E2F4 and hMSH3 genes in colorectal cancers with microsatellite instability. Cancer Res 58:594\u2013598","journal-title":"Cancer Res"},{"key":"2892_CR66","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ajhg.2016.06.015","volume":"99","author":"R Adam","year":"2016","unstructured":"Adam R, Spier I, Zhao B et al (2016) Exome sequencing identifies biallelic MSH3 germline mutations as a recessive subtype of colorectal adenomatous polyposis. Am J Hum Genet 99:337\u2013351","journal-title":"Am J Hum Genet"},{"key":"2892_CR67","doi-asserted-by":"publisher","DOI":"10.1200\/PO.20.00443","volume":"5","author":"EE Salo-Mullen","year":"2021","unstructured":"Salo-Mullen EE, Maio A, Mukherjee S et al (2021) Prevalence and characterization of biallelic and monoallelic NTHL1 and MSH3 variant carriers from a pan-cancer patient population. JCO Precis Oncol 5:PO.20.00443. https:\/\/doi.org\/10.1200\/PO.20.00443","journal-title":"JCO Precis Oncol"},{"issue":"8","key":"2892_CR68","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1038\/s41436-018-0405-x","volume":"21","author":"A Olkinuora","year":"2019","unstructured":"Olkinuora A, Nieminen TT, Martensson E et al (2019) Biallelic germline nonsense variant of MLH3 underlies polyposis predisposition. Genet Med 21(8):1868\u20131873","journal-title":"Genet Med"},{"key":"2892_CR69","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s10038-021-00907-z","volume":"66","author":"S Nawaz","year":"2021","unstructured":"Nawaz S, Ullah MI, Hamid BS et al (2021) A loss-of-function variant in DNA mismatch repair gene MLH3 underlies severe oligozoospermia. J Hum Genet 66:725\u2013730. https:\/\/doi.org\/10.1038\/s10038-021-00907-z","journal-title":"J Hum Genet"},{"key":"2892_CR70","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1093\/hmg\/ddaa101","volume":"29","author":"S Chen","year":"2020","unstructured":"Chen S, Wang G, Zheng X et al (2020) Whole-exome sequencing of a large Chinese azoospermia and severe oligospermia cohort identifies novel infertility causative variants and genes. Hum Mol Genet 29:2451\u20132459. https:\/\/doi.org\/10.1093\/hmg\/ddaa101","journal-title":"Hum Mol Genet"},{"key":"2892_CR71","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a012583","volume":"5","author":"HE Krokan","year":"2013","unstructured":"Krokan HE, Bj\u00f8r\u00e5s M (2013) Base excision repair. Cold Spring Harb Perspect Biol 5:a012583","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2892_CR72","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ng.3287","volume":"47","author":"RD Weren","year":"2015","unstructured":"Weren RD, Ligtenberg MJ, Kets CM et al (2015) A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer. Nat Genet 47:668\u2013671. https:\/\/doi.org\/10.1038\/ng.3287","journal-title":"Nat Genet"},{"key":"2892_CR73","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1056\/NEJMc1506878","volume":"373","author":"B Rivera","year":"2015","unstructured":"Rivera B, Castellsagu\u00e9 E, Bah I et al (2015) Biallelic NTHL1 mutations in a woman with multiple primary tumors. N Engl J Med 373:1985\u20131986","journal-title":"N Engl J Med"},{"issue":"75\u201377","key":"2892_CR74","volume":"152","author":"P Broderick","year":"2017","unstructured":"Broderick P, Dobbins SE, Chubb D et al (2017) Validation of recently proposed colorectal cancer susceptibility gene variants in an analysis of families and patients - A systematic review. Gastroenterology 152(75\u201377):e4","journal-title":"Gastroenterology"},{"key":"2892_CR75","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ccell.2018.12.011","volume":"35","author":"JE Grolleman","year":"2019","unstructured":"Grolleman JE, de Voer RM, Elsayed FA et al (2019) Mutational signature analysis reveals NTHL1 deficiency to cause a multi-tumor phenotype. Cancer Cell 35:256-266.e5","journal-title":"Cancer Cell"},{"key":"2892_CR76","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1053\/j.gastro.2020.08.042","volume":"159","author":"FA Elsayed","year":"2020","unstructured":"Elsayed FA, Grolleman JE, Ragunathan A et al (2020) Monoallelic NTHL1 loss-of-function variants and risk of polyposis and colorectal cancer. Gastroenterology 159:2241-2243.e6","journal-title":"Gastroenterology"},{"key":"2892_CR77","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.ajhg.2022.03.018","volume":"109","author":"C Palles","year":"2022","unstructured":"Palles C, West HD, Chew E et al (2022) Germline MBD4 deficiency causes a multi-tumor predisposition syndrome. Am J Hum Genet 109:953\u2013960","journal-title":"Am J Hum Genet"},{"key":"2892_CR78","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3892\/or.2019.7239","volume":"42","author":"K Tanakaya","year":"2019","unstructured":"Tanakaya K, Kumamoto K, Tada Y et al (2019) A germline MBD4 mutation was identified in a patient with colorectal oligopolyposis and early-onset cancer: a case report. Oncol Rep 42:1133\u20131140. https:\/\/doi.org\/10.3892\/or.2019.7239","journal-title":"Oncol Rep"},{"key":"2892_CR79","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1086\/386293","volume":"74","author":"L Lammi","year":"2004","unstructured":"Lammi L, Arte S, Somer M et al (2004) Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet 74:1043\u20131050","journal-title":"Am J Hum Genet"},{"key":"2892_CR80","first-page":"131","volume":"38","author":"A Hlouskova","year":"2017","unstructured":"Hlouskova A, Bielik P, Bonczek O et al (2017) Mutations in AXIN2 gene as a risk factor for tooth agenesis and cancer: A review. Neuro Endocrinol Lett 38:131\u2013137","journal-title":"Neuro Endocrinol Lett"},{"key":"2892_CR81","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33927","author":"ML Marvin","year":"2011","unstructured":"Marvin ML, Mazzoni SM, Herron CM et al (2011) AXIN2-associated autosomal dominant ectodermal dysplasia and neoplastic syndrome. Am J Med Genet. https:\/\/doi.org\/10.1002\/ajmg.a.33927","journal-title":"Am J Med Genet"},{"key":"2892_CR82","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/gim.2014.30","volume":"16","author":"BH Shirts","year":"2014","unstructured":"Shirts BH, Salipante SJ, Casadei S et al (2014) Deep sequencing with intronic capture enables identification of an APC exon 10 inversion in a patient with polyposis. Genet Med 16:783\u2013786","journal-title":"Genet Med"},{"key":"2892_CR83","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/gcc.2870130309","volume":"13","author":"RB van der Luijt","year":"1995","unstructured":"van der Luijt RB, Tops CM, Khan PM et al (1995) Molecular, cytogenetic, and phenotypic studies of a constitutional reciprocal translocation t(5;10)(q22;q25) responsible for familial adenomatous polyposis in a Dutch pedigree. Genes Chromosomes Cancer 13:192\u2013202","journal-title":"Genes Chromosomes Cancer"},{"key":"2892_CR84","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10689-021-00236-2","volume":"21","author":"FA Elsayed","year":"2022","unstructured":"Elsayed FA, Tops CMJ, Nielsen M et al (2022) Use of Sanger and next-generation sequencing to screen for mosaic and intronic APC variants in unexplained colorectal polyposis patients. Fam Cancer 21:79\u201383","journal-title":"Fam Cancer"},{"key":"2892_CR85","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41431-023-01322-y","volume":"31","author":"A Bozsik","year":"2023","unstructured":"Bozsik A, Butz H, Grolmusz VK et al (2023) Genome sequencing-based discovery of a novel deep intronic APC pathogenic variant causing exonization. Eur J Hum Genet 31:841\u2013845. https:\/\/doi.org\/10.1038\/s41431-023-01322-y","journal-title":"Eur J Hum Genet"},{"key":"2892_CR86","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/gcc.22197","volume":"53","author":"W Pavicic","year":"2014","unstructured":"Pavicic W, Nieminen TT, Gylling A et al (2014) Promoter-specific alterations of APC are a rare cause for mutation-negative familial adenomatous polyposis. Genes Chromosomes Cancer 53:857\u2013864. https:\/\/doi.org\/10.1002\/gcc.22197","journal-title":"Genes Chromosomes Cancer"},{"key":"2892_CR87","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.gie.2015.12.029","volume":"84","author":"PM Lynch","year":"2016","unstructured":"Lynch PM, Morris JS, Wen S et al (2016) A proposed staging system and stage-specific interventions for familial adenomatous polyposis. Gastrointest Endosc 84:115-125.e114","journal-title":"Gastrointest Endosc"},{"key":"2892_CR88","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10689-016-9905-5","volume":"15","author":"S Septer","year":"2016","unstructured":"Septer S, Lawson CE, Anant S et al (2016) Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate. Fam Cancer 15:477\u2013485","journal-title":"Fam Cancer"},{"key":"2892_CR89","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/jmg.33.2.157","volume":"33","author":"S Distante","year":"1996","unstructured":"Distante S, Nasioulas S, Somers GR et al (1996) Familial adenomatous polyposis in a 5 year old child: a clinical, pathological, and molecular genetic study. J Med Genet 33:157\u2013160","journal-title":"J Med Genet"},{"key":"2892_CR90","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1399-0004.2007.00766.x","volume":"71","author":"M Nielsen","year":"2007","unstructured":"Nielsen M, Hes FJ, Nagengast FM et al (2007) Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clin Genet 71:427\u2013433. https:\/\/doi.org\/10.1111\/j.1399-0004.2007.00766.x","journal-title":"Clin Genet"},{"key":"2892_CR91","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1053\/j.gastro.2004.05.003","volume":"127","author":"RW Burt","year":"2004","unstructured":"Burt RW, Leppert MF, Slattery ML et al (2004) Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology 127:444\u2013451","journal-title":"Gastroenterology"},{"key":"2892_CR92","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-0042-101384","volume":"48","author":"H Ishikawa","year":"2016","unstructured":"Ishikawa H, Mutoh M, Iwama T et al (2016) Endoscopic management of familial adenomatous polyposis in patients refusing colectomy. Endoscopy 48:51\u201355","journal-title":"Endoscopy"},{"key":"2892_CR93","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1055\/a-1945-9120","volume":"55","author":"H Ishikawa","year":"2023","unstructured":"Ishikawa H, Yamada M, Sato Y et al (2023) Intensive endoscopic resection for downstaging of polyp burden in patients with familial adenomatous polyposis (J-FAPP study \u2162): a multicenter prospective interventional study. Endoscopy 55:344\u2013352","journal-title":"Endoscopy"},{"key":"2892_CR94","first-page":"10","volume":"79","author":"T Iwama","year":"1978","unstructured":"Iwama T (1978) A pathomorphological study of adenomatous polyposis. J Jpn Surg Soc 79:10\u201324","journal-title":"J Jpn Surg Soc"},{"key":"2892_CR95","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1136\/gut.2004.042705","volume":"53","author":"NJ Sturt","year":"2004","unstructured":"Sturt NJ, Gallagher MC, Bassett P et al (2004) Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut 53:1832\u20131836","journal-title":"Gut"},{"key":"2892_CR96","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10689-005-5674-2","volume":"5","author":"P Rozen","year":"2006","unstructured":"Rozen P, Macrae F (2006) Familial adenomatous polyposis: the practical applications of clinical and molecular screening. Fam Cancer 5:227\u2013235","journal-title":"Fam Cancer"},{"key":"2892_CR97","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s10147-023-02419-6","volume":"28","author":"Y Mori","year":"2023","unstructured":"Mori Y, Ishida H, Chika N et al (2023) Usefulness of genotyping APC gene for individualizing management of patients with familial adenomatous polyposis. Int J Clin Oncol 28:1641\u20131650","journal-title":"Int J Clin Oncol"},{"key":"2892_CR98","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/gut.49.4.540","volume":"49","author":"MD Crabtree","year":"2001","unstructured":"Crabtree MD, Tomlinson IP, Talbot IC et al (2001) Variability in the severity of colonic disease in familial adenomatous polyposis results from differences in tumour initiation rather than progression and depends relatively little on patient age. Gut 49:540\u2013543","journal-title":"Gut"},{"key":"2892_CR99","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/bjs.4082","volume":"90","author":"K\u00d8 Olsen","year":"2003","unstructured":"Olsen K\u00d8, Juul S, B\u00fclow S et al (2003) Female fecundity before and after operation for familial adenomatous polyposis. Br J Surg 90:227\u2013231","journal-title":"Br J Surg"},{"key":"2892_CR100","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0039-6060(96)80185-1","volume":"119","author":"AH Kartheuser","year":"1996","unstructured":"Kartheuser AH, Parc R, Penna CP et al (1996) Ileal pouch-anal anastomosis as the first choice operation in patients with familial adenomatous polyposis: a ten-year experience. Surgery 119:615\u2013623","journal-title":"Surgery"},{"key":"2892_CR101","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1023\/A:1013888226756","volume":"1","author":"P Rozen","year":"2001","unstructured":"Rozen P, Samuel Z, Rabau M et al (2001) Familial adenomatous polyposis at the Tel Aviv medical center: demographic and clinical features. Fam Cancer 1:75\u201382","journal-title":"Fam Cancer"},{"key":"2892_CR102","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/adc.77.5.431","volume":"77","author":"DM Eccles","year":"1997","unstructured":"Eccles DM, Lunt PW, Wallis Y et al (1997) An unusually severe phenotype for familial adenomatous polyposis. Arch Dis Child 77:431\u2013435","journal-title":"Arch Dis Child"},{"key":"2892_CR103","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/gut.49.2.231","volume":"49","author":"HF Vasen","year":"2001","unstructured":"Vasen HF, van Duijvendijk P, Buskens E et al (2001) Decision analysis in the surgical treatment of patients with familial adenomatous polyposis: a Dutch-Scandinavian collaborative study including 659 patients. Gut 49:231\u2013235","journal-title":"Gut"},{"key":"2892_CR104","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10689-005-5672-4","volume":"5","author":"A Kartheuser","year":"2006","unstructured":"Kartheuser A, Stangherlin P, Brandt D et al (2006) Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited. Fam Cancer 5:241\u2013260. https:\/\/doi.org\/10.1007\/s10689-005-5672-4","journal-title":"Fam Cancer"},{"key":"2892_CR105","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s10147-016-0953-5","volume":"21","author":"H Ueno","year":"2016","unstructured":"Ueno H, Kobayashi H, Konishi T et al (2016) Prevalence of laparoscopic surgical treatment and its clinical outcomes in patients with familial adenomatous polyposis in Japan. Int J Clin Oncol 21:713\u2013722","journal-title":"Int J Clin Oncol"},{"key":"2892_CR106","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s10147-016-0977-x","volume":"21","author":"T Konishi","year":"2016","unstructured":"Konishi T, Ishida H, Ueno H et al (2016) Feasibility of laparoscopic total proctocolectomy with ileal pouch-anal anastomosis and total colectomy with ileorectal anastomosis for familial adenomatous polyposis: results of a nationwide multicenter study. Int J Clin Oncol 21:953\u2013961","journal-title":"Int J Clin Oncol"},{"key":"2892_CR107","doi-asserted-by":"publisher","first-page":"16620","DOI":"10.3748\/wjg.v20.i44.16620","volume":"20","author":"FG Campos","year":"2014","unstructured":"Campos FG (2014) Surgical treatment of familial adenomatous polyposis: dilemmas and current recommendations. World J Gastroenterol 20:16620\u201316629","journal-title":"World J Gastroenterol"},{"key":"2892_CR108","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1007\/s00268-014-2557-4","volume":"38","author":"MD Kjaer","year":"2014","unstructured":"Kjaer MD, Laursen SB, Qvist N et al (2014) Sexual function and body image are similar after laparoscopy-assisted and open ileal pouch-anal anastomosis. World J Surg 38:2460\u20132465. https:\/\/doi.org\/10.1007\/s00268-014-2557-4","journal-title":"World J Surg"},{"key":"2892_CR109","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jamcollsurg.2010.05.018","volume":"211","author":"AD Fajardo","year":"2010","unstructured":"Fajardo AD, Dharmarajan S, George V et al (2010) Laparoscopic versus open 2-stage ileal pouch: laparoscopic approach allows for faster restoration of intestinal continuity. J Am Coll Surg 211:377\u2013383","journal-title":"J Am Coll Surg"},{"key":"2892_CR110","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/DCR.0b013e3181ab58fb","volume":"52","author":"A da Luz Moreira","year":"2009","unstructured":"da Luz Moreira A, Church JM, Burke CA (2009) The evolution of prophylactic colorectal surgery for familial adenomatous polyposis. Dis Colon Rectum 52:1481\u20131486","journal-title":"Dis Colon Rectum"},{"key":"2892_CR111","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/bjs5.90","volume":"2","author":"A Sinha","year":"2018","unstructured":"Sinha A, Burns EM, Latchford A et al (2018) Risk of desmoid formation after laparoscopic versus open colectomy and ileorectal anastomosis for familial adenomatous polyposis. BJS Open 2:452\u2013455. https:\/\/doi.org\/10.1002\/bjs5.90","journal-title":"BJS Open"},{"key":"2892_CR112","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/ans.13919","volume":"87","author":"TJ Chittleborough","year":"2017","unstructured":"Chittleborough TJ, Warrier SK, Heriot AG et al (2017) Dispelling misconceptions in the management of familial adenomatous polyposis. ANZ J Surg 87:441\u2013445. https:\/\/doi.org\/10.1111\/ans.13919","journal-title":"ANZ J Surg"},{"key":"2892_CR113","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/BF00303276","volume":"5","author":"C Johansen","year":"1990","unstructured":"Johansen C, Bitsch M, B\u00fclow S (1990) Fertility and pregnancy in women with familial adenomatous polyposis. Int J Colorectal Dis 5:203\u2013206","journal-title":"Int J Colorectal Dis"},{"key":"2892_CR114","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/SLA.0b013e3181e9829f","volume":"252","author":"MH Nieuwenhuis","year":"2010","unstructured":"Nieuwenhuis MH, Douma KF, Bleiker EM et al (2010) Female fertility after colorectal surgery for familial adenomatous polyposis: a nationwide cross-sectional study. Ann Surg 252:341\u2013344","journal-title":"Ann Surg"},{"key":"2892_CR115","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF00699417","volume":"9","author":"T Oresland","year":"1994","unstructured":"Oresland T, Palmblad S, Ellstrom M et al (1994) Gynaecological and sexual function related to anatomical changes in the female pelvis after restorative proctocolectomy. Int J Colorectal Dis 9:77\u201381","journal-title":"Int J Colorectal Dis"},{"key":"2892_CR116","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/SLA.0b013e318250caa9","volume":"256","author":"SA Bartels","year":"2012","unstructured":"Bartels SA, D\u2019Hoore A, Cuesta MA et al (2012) Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy: a cross-sectional study. Ann Surg 256:1045\u20131048","journal-title":"Ann Surg"},{"key":"2892_CR117","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s10350-005-0124-7","volume":"48","author":"FH Remzi","year":"2005","unstructured":"Remzi FH, Gorgun E, Bast J et al (2005) Vaginal delivery after ileal pouch-anal anastomosis: a word of caution. Dis Colon Rectum 48:1691\u20131699","journal-title":"Dis Colon Rectum"},{"key":"2892_CR118","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF02052444","volume":"38","author":"ES Juhasz","year":"1995","unstructured":"Juhasz ES, Fozard B, Dozois RR et al (1995) Ileal pouch-anal anastomosis function following childbirth. An extended evaluation. Dis Colon Rectum 38:159\u2013165","journal-title":"Dis Colon Rectum"},{"key":"2892_CR119","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/01.sla.0000114216.90947.f6","volume":"239","author":"Y Parc","year":"2004","unstructured":"Parc Y, Piquard A, Dozois RR et al (2004) Long-term outcome of familial adenomatous polyposis patients after restorative coloproctectomy. Ann Surg 239:378\u2013382","journal-title":"Ann Surg"},{"key":"2892_CR120","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/BF02234731","volume":"44","author":"MW Thompson-Fawcett","year":"2001","unstructured":"Thompson-Fawcett MW, Marcus VA, Redston M et al (2001) Adenomatous polyps develop commonly in the ileal pouch of patients with familial adenomatous polyposis. Dis Colon Rectum 44:347\u2013353","journal-title":"Dis Colon Rectum"},{"key":"2892_CR121","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s10350-004-0835-1","volume":"48","author":"CJ Groves","year":"2005","unstructured":"Groves CJ, Beveridge LG, Swain DJ et al (2005) Prevalence and morphology of pouch and ileal adenomas in familial adenomatous polyposis. Dis Colon Rectum 48:816\u2013823","journal-title":"Dis Colon Rectum"},{"key":"2892_CR122","doi-asserted-by":"publisher","first-page":"6774","DOI":"10.3748\/wjg.v19.i40.6774","volume":"19","author":"M Tajika","year":"2013","unstructured":"Tajika M, Niwa Y, Bhatia V et al (2013) Risk of ileal pouch neoplasms in patients with familial adenomatous polyposis. World J Gastroenterol 19:6774\u20136783","journal-title":"World J Gastroenterol"},{"key":"2892_CR123","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/BF02050149","volume":"37","author":"JC Hoehner","year":"1994","unstructured":"Hoehner JC, Metcalf AM (1994) Development of invasive adenocarcinoma following colectomy with ileoanal anastomosis for familial polyposis coli. Report of a case. Dis Colon Rectum 37:824\u2013828","journal-title":"Dis Colon Rectum"},{"key":"2892_CR124","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/DCR.0b013e318199effe","volume":"52","author":"GT Ault","year":"2009","unstructured":"Ault GT, Nunoo-Mensah JW, Johnson L et al (2009) Adenocarcinoma arising in the middle of ileoanal pouches: report of five cases. Dis Colon Rectum 52:538\u2013541","journal-title":"Dis Colon Rectum"},{"key":"2892_CR125","doi-asserted-by":"publisher","first-page":"9665","DOI":"10.3748\/wjg.v20.i29.9665","volume":"20","author":"I Angriman","year":"2014","unstructured":"Angriman I, Scarpa M, Castagliuolo I (2014) Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis. World J Gastroenterol 20:9665\u20139674","journal-title":"World J Gastroenterol"},{"key":"2892_CR126","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00384-013-1796-4","volume":"29","author":"L Koskenvuo","year":"2014","unstructured":"Koskenvuo L, Renkonen-Sinisalo L, J\u00e4rvinen HJ et al (2014) Risk of cancer and secondary proctectomy after colectomy and ileorectal anastomosis in familial adenomatous polyposis. Int J Colorectal Dis 29:225\u2013230. https:\/\/doi.org\/10.1007\/s00384-013-1796-4","journal-title":"Int J Colorectal Dis"},{"key":"2892_CR127","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1590\/S0004-28032009000400009","volume":"46","author":"FG Campos","year":"2009","unstructured":"Campos FG, Perez RO, Imperiale AR et al (2009) Surgical treatment of familial adenomatous polyposis: ileorectal anastomosis or restorative proctolectomy? Arq Gastroenterol 46:294\u2013299. https:\/\/doi.org\/10.1590\/S0004-28032009000400009","journal-title":"Arq Gastroenterol"},{"key":"2892_CR128","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/DCR.0b013e3181a0d33b","volume":"52","author":"MH Nieuwenhuis","year":"2009","unstructured":"Nieuwenhuis MH, B\u00fclow S, Bj\u00f6rk J et al (2009) Genotype predicting phenotype in familial adenomatous polyposis: a practical application to the choice of surgery. Dis Colon Rectum 52:1259\u20131263","journal-title":"Dis Colon Rectum"},{"key":"2892_CR129","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1007\/s10350-008-9307-3","volume":"51","author":"S B\u00fclow","year":"2008","unstructured":"B\u00fclow S, B\u00fclow C, Vasen H et al (2008) Colectomy and ileorectal anastomosis is still an option for selected patients with familial adenomatous polyposis. Dis Colon Rectum 51:1318\u20131323","journal-title":"Dis Colon Rectum"},{"key":"2892_CR130","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s10350-004-7273-y","volume":"46","author":"J Church","year":"2003","unstructured":"Church J, Simmang C, Standards Task Force; American Society of Colon and Rectal Surgeons; Collaborative Group of the Americas on Inherited Colorectal Cancer and the Standards Committee of The American Society of Colon and Rectal Surgeons (2003) Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer). Dis Colon Rectum 46:1001\u20131012","journal-title":"Dis Colon Rectum"},{"key":"2892_CR131","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.cgh.2007.11.018","volume":"6","author":"LK Bianchi","year":"2008","unstructured":"Bianchi LK, Burke CA, Bennett AE et al (2008) Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol 6:180\u2013185","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2892_CR132","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/jjco\/hyac029","volume":"52","author":"A Takao","year":"2022","unstructured":"Takao A, Koizumi K, Takao M et al (2022) Upper gastrointestinal tumors are unrelated to the APC genotype in APC-associated polyposis. Jpn J Clin Oncol 52:554\u2013561","journal-title":"Jpn J Clin Oncol"},{"key":"2892_CR133","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.gie.2021.06.010","volume":"94","author":"Y Shimamoto","year":"2021","unstructured":"Shimamoto Y, Ishiguro S, Takeuchi Y et al (2021) Gastric neoplasms in patients with familial adenomatous polyposis: endoscopic and clinicopathologic features. Gastrointest Endosc 94:1030-1042.e2","journal-title":"Gastrointest Endosc"},{"key":"2892_CR134","first-page":"192","volume":"31","author":"G Bertoni","year":"1999","unstructured":"Bertoni G, Sassatelli R, Nigrisoli E et al (1999) Dysplastic changes in gastric fundic gland polyps of patients with familial adenomatous polyposis. Ital J Gastroenterol Hepatol 31:192\u2013197","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"2892_CR135","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000030997","volume":"101","author":"M Kobashi","year":"2022","unstructured":"Kobashi M, Iwamuro M, Kuraoka S et al (2022) Endoscopic findings of gastric neoplasms in familial adenomatous polyposis are associated with the phenotypic variations and grades of dysplasia. Medicine (Baltimore) 101:e30997","journal-title":"Medicine (Baltimore)"},{"key":"2892_CR136","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1897-4287-12-4","volume":"12","author":"S Ngamruengphong","year":"2014","unstructured":"Ngamruengphong S, Boardman LA, Heigh RI et al (2014) Gastric adenomas in familial adenomatous polyposis are common but subtle, and have a benign course. Hered Cancer Clin Pract 12:4. https:\/\/doi.org\/10.1186\/1897-4287-12-4","journal-title":"Hered Cancer Clin Pract"},{"key":"2892_CR137","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/S0140-6736(89)90840-4","volume":"2","author":"AD Spigelman","year":"1989","unstructured":"Spigelman AD, Williams CB, Talbot IC et al (1989) Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 2:783\u2013785","journal-title":"Lancet"},{"key":"2892_CR138","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.gie.2020.01.028","volume":"91","author":"J Yang","year":"2020","unstructured":"Yang J, Gurudu SR, Koptiuch C et al (2020) American society for gastrointestinal endoscopy guideline on the role of endoscopy in familial adenomatous polyposis syndromes. Gastrointest Endosc 91:963-982.e2","journal-title":"Gastrointest Endosc"},{"key":"2892_CR139","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0016-5085(89)80017-4","volume":"96","author":"M Iida","year":"1989","unstructured":"Iida M, Yao T, Itoh H et al (1989) Natural history of duodenal lesions in Japanese patients with familial adenomatosiscoli (Gardner\u02bcs syndrome). Gastroenterology 96:1301\u20131306","journal-title":"Gastroenterology"},{"key":"2892_CR140","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S1091-255X(02)00062-8","volume":"6","author":"KL Moozar","year":"2002","unstructured":"Moozar KL, Madlensky L, Berk T et al (2002) Slow progression of periampullary neoplasia in familial adenomatous polyposis. J Gastrointest Surg 6:831\u2013837. https:\/\/doi.org\/10.1016\/S1091-255X(02)00062-8","journal-title":"J Gastrointest Surg"},{"key":"2892_CR141","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1136\/gut.2004.053843","volume":"54","author":"LA Brosens","year":"2005","unstructured":"Brosens LA, Keller JJ, Offerhaus GJ et al (2005) Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut 54:1034\u20131043. https:\/\/doi.org\/10.1136\/gut.2004.053843","journal-title":"Gut"},{"key":"2892_CR142","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/jjco\/hyv210","volume":"46","author":"T Yamaguchi","year":"2016","unstructured":"Yamaguchi T, Ishida H, Ueno H et al (2016) Upper gastrointestinal tumours in Japanese familial adenomatous polyposis patients. Jpn J Clin Oncol 46:310\u2013315. https:\/\/doi.org\/10.1093\/jjco\/hyv210","journal-title":"Jpn J Clin Oncol"},{"key":"2892_CR143","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.gie.2014.03.012","volume":"80","author":"D Moussata","year":"2014","unstructured":"Moussata D, Napoleon B, Lepilliez V et al (2014) Endoscopic treatment of severe duodenal polyposis as an alternative to surgery for patients with familial adenomatous polyposis. Gastrointest Endosc 80:817\u2013825","journal-title":"Gastrointest Endosc"},{"key":"2892_CR144","doi-asserted-by":"publisher","first-page":"343","DOI":"10.14309\/ajg.0000000000001582","volume":"117","author":"JG Karstensen","year":"2022","unstructured":"Karstensen JG, B\u00fclow S, Burisch J et al (2022) Validation of the endoscopic part of the Spigelman classification for evaluating duodenal adenomatosis in familial adenomatous polyposis: a prospective study of interrater and intrarater reliability. Am J Gastroenterol 117:343\u2013345","journal-title":"Am J Gastroenterol"},{"key":"2892_CR145","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1080\/003655299750025741","volume":"34","author":"TS Galle","year":"1999","unstructured":"Galle TS, Juel K, B\u00fclow S (1999) Causes of death in familial adenomatous polyposis. Scand J Gastroenterol 34:808\u2013812","journal-title":"Scand J Gastroenterol"},{"key":"2892_CR146","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1016\/0016-5085(92)90322-P","volume":"102","author":"GJ Offerhaus","year":"1992","unstructured":"Offerhaus GJ, Giardiello FM, Krush AJ et al (1992) The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 102:1980\u20131982","journal-title":"Gastroenterology"},{"key":"2892_CR147","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/BF02253505","volume":"35","author":"JG Park","year":"1992","unstructured":"Park JG, Park KJ, Ahn YO et al (1992) Risk of gastric cancer among Korean familial adenomatous polyposis patients. Report of three cases. Dis Colon Rectum 35:996\u2013998","journal-title":"Dis Colon Rectum"},{"key":"2892_CR148","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/gut.2003.027771","volume":"53","author":"S B\u00fclow","year":"2004","unstructured":"B\u00fclow S, Bj\u00f6rk J, Christensen IJ et al (2004) Duodenal adenomatosis in familial adenomatous polyposis. Gut 53:381\u2013386","journal-title":"Gut"},{"key":"2892_CR149","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1053\/gast.2001.28707","volume":"121","author":"J Bj\u00f6rk","year":"2001","unstructured":"Bj\u00f6rk J, Akerbrant H, Iselius L et al (2001) Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology 121:1127\u20131135","journal-title":"Gastroenterology"},{"key":"2892_CR150","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1200\/JCO.2004.06.028","volume":"22","author":"JC Saurin","year":"2004","unstructured":"Saurin JC, Gutknecht C, Napoleon B et al (2004) Surveillance of duodenal adenomas in familial adenomatous polyposis reveals high cumulative risk of advanced disease. J Clin Oncol 22:493\u2013498","journal-title":"J Clin Oncol"},{"key":"2892_CR151","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.gie.2012.11.033","volume":"77","author":"M Lopez-Ceron","year":"2013","unstructured":"Lopez-Ceron M, van den Broek FJ, Mathus-Vliegen EM et al (2013) The role of high-resolution endoscopy and narrow-band imaging in the evaluation of upper GI neoplasia in familial adenomatous polyposis. Gastrointest Endosc 77:542\u2013550","journal-title":"Gastrointest Endosc"},{"key":"2892_CR152","first-page":"563","volume":"32","author":"M Iida","year":"1997","unstructured":"Iida M, Hizawa K, Matsumoto T et al (1997) Long-term course of gastric and duodenal lesions in familial adenomatous polyposis. Stomach Intest 32:563\u2013576","journal-title":"Stomach Intest"},{"key":"2892_CR153","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.gie.2021.09.036","volume":"95","author":"AD Singh","year":"2022","unstructured":"Singh AD, Bhatt A, Joseph A et al (2022) Natural history of ampullary adenomas in familial adenomatous polyposis: a long-term follow-up study. Gastrointest Endosc 95:455-467.e3","journal-title":"Gastrointest Endosc"},{"key":"2892_CR154","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.cgh.2020.05.054","volume":"19","author":"NA Mehta","year":"2021","unstructured":"Mehta NA, Shah RS, Yoon J et al (2021) Risks, benefits, and effects on management for biopsy of the papilla in patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol 19:760\u2013767","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2892_CR155","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s10689-017-0063-1","volume":"17","author":"K Inoki","year":"2018","unstructured":"Inoki K, Nakajima T, Nonaka S et al (2018) Feasibility of endoscopic resection using bipolar snare for nonampullary duodenal tumours in familial adenomatous polyposis patients. Fam Cancer 17:517\u2013524","journal-title":"Fam Cancer"},{"key":"2892_CR156","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1007\/s10620-016-4165-7","volume":"61","author":"K Hamada","year":"2016","unstructured":"Hamada K, Takeuchi Y, Ishikawa H et al (2016) Feasibility of cold snare polypectomy for multiple duodenal adenomas in patients with familial adenomatous polyposis: a pilot study. Dig Dis Sci 61:2755\u20132759","journal-title":"Dig Dis Sci"},{"key":"2892_CR157","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1055\/s-0043-124765","volume":"50","author":"K Hamada","year":"2018","unstructured":"Hamada K, Takeuchi Y, Ishikawa H et al (2018) Safety of cold snare polypectomy for duodenal adenomas in familial adenomatous polyposis: a prospective exploratory study. Endoscopy 50:511\u2013517","journal-title":"Endoscopy"},{"key":"2892_CR158","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.vgie.2019.07.004","volume":"4","author":"H Nakahira","year":"2019","unstructured":"Nakahira H, Takeuchi Y, Kanesaka T et al (2019) Wide-field underwater EMR followed by line-assisted complete closure for a large duodenal adenoma. VideoGIE 4:469\u2013471","journal-title":"VideoGIE"},{"key":"2892_CR159","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/BF02236201","volume":"42","author":"FJ Alarcon","year":"1999","unstructured":"Alarcon FJ, Burke CA, Church JM et al (1999) Familial adenomatous polyposis: efficacy of endoscopic and surgical treatment for advanced duodenal adenomas. Dis Colon Rectum 42:1533\u20131536","journal-title":"Dis Colon Rectum"},{"key":"2892_CR160","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000516561","volume":"40","author":"Y Yabuuchi","year":"2022","unstructured":"Yabuuchi Y, Yoshida M, Kakushima N et al (2022) Risk factors for non-ampullary duodenal adenocarcinoma: a systematic review. Dig Dis 40:147\u2013155. https:\/\/doi.org\/10.1159\/000516561","journal-title":"Dig Dis"},{"key":"2892_CR161","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/gut.50.5.636","volume":"50","author":"CJ Groves","year":"2002","unstructured":"Groves CJ, Saunders BP, Spigelman AD et al (2002) Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut 50:636\u2013641","journal-title":"Gut"},{"key":"2892_CR162","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1007\/s00464-021-08406-0","volume":"36","author":"JH Noh","year":"2022","unstructured":"Noh JH, Song EM, Ahn JY et al (2022) Prevalence and endoscopic treatment outcomes of upper gastrointestinal neoplasms in familial adenomatous polyposis. Surg Endosc 36:1310\u20131319","journal-title":"Surg Endosc"},{"key":"2892_CR163","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.gie.2020.05.065","volume":"93","author":"VH Roos","year":"2021","unstructured":"Roos VH, Bastiaansen BA, Kallenberg FGJ et al (2021) Endoscopic management of duodenal adenomas in patients with familial adenomatous polyposis. Gastrointest Endosc 93:457\u2013466","journal-title":"Gastrointest Endosc"},{"key":"2892_CR164","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.hbpd.2021.02.007","volume":"20","author":"J Busquets","year":"2021","unstructured":"Busquets J, Lopez-Dominguez J, Gonzalez-Castillo A et al (2021) Pancreas sparing duodenectomy in the treatment of primary duodenal neoplasms and other situations with duodenal involvement. Hepatobiliary Pancreat Dis Int 20:485\u2013492. https:\/\/doi.org\/10.1016\/j.hbpd.2021.02.007","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"2892_CR165","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s11605-020-04621-7","volume":"25","author":"R Naples","year":"2021","unstructured":"Naples R, Simon R, Moslim M et al (2021) Long-term outcomes of pancreas-sparing duodenectomy for duodenal polyposis in familial adenomatous polyposis syndrome. J Gastrointest Surg 25:1233\u20131240. https:\/\/doi.org\/10.1007\/s11605-020-04621-7","journal-title":"J Gastrointest Surg"},{"key":"2892_CR166","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.hpb.2022.04.004","volume":"24","author":"AS Aelvoet","year":"2022","unstructured":"Aelvoet AS, Bastiaansen BAJ, Fockens P et al (2022) Pancreas-preserving total duodenectomy for advanced duodenal polyposis in patients with familial adenomatous polyposis: short and long-term outcomes. HPB (Oxford) 24:1642\u20131650","journal-title":"HPB (Oxford)"},{"key":"2892_CR167","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.gie.2020.02.040","volume":"92","author":"P Angsuwatcharakon","year":"2020","unstructured":"Angsuwatcharakon P, Ahmed O, Lynch PM et al (2020) Management of ampullary adenomas in familial adenomatous polyposis syndrome: 16 years of experience from a tertiary cancer center. Gastrointest Endosc 92:323\u2013330","journal-title":"Gastrointest Endosc"},{"key":"2892_CR168","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/00000658-199302000-00002","volume":"217","author":"T Iwama","year":"1993","unstructured":"Iwama T, Mishima Y, Utsunomiya J (1993) The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment. Ann Surg 217:101\u2013108","journal-title":"Ann Surg"},{"key":"2892_CR169","first-page":"111","volume":"1","author":"AL Knudsen","year":"2001","unstructured":"Knudsen AL, Bulow S (2001) Desmoid tumour in familial adenomatous polyposis. A review of literature Fam Cancer 1:111\u2013119","journal-title":"A review of literature Fam Cancer"},{"key":"2892_CR170","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cgh.2007.11.011","volume":"6","author":"MH Nieuwenhuis","year":"2008","unstructured":"Nieuwenhuis MH, De Vos Tot Nederveen Cappel W, Botma A et al (2008) Desmoid tumors in a Dutch cohort of patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol 6:215\u2013219","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2892_CR171","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/bjs.5633","volume":"94","author":"D Speake","year":"2007","unstructured":"Speake D, Evans DG, Lalloo F et al (2007) Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutations. Br J Surg 94:1009\u20131013. https:\/\/doi.org\/10.1002\/bjs.5633","journal-title":"Br J Surg"},{"key":"2892_CR172","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1245\/s10434-016-5380-3","volume":"23","author":"Y Saito","year":"2016","unstructured":"Saito Y, Hinoi T, Ueno H et al (2016) Risk factors for the development of desmoid tumor after colectomy in patients with familial adenomatous polyposis: Multicenter retrospective cohort study in Japan. Ann Surg Oncol 23:559\u2013565","journal-title":"Ann Surg Oncol"},{"key":"2892_CR173","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/cas.13123","volume":"108","author":"T Yamano","year":"2017","unstructured":"Yamano T, Hamanaka M, Babaya A et al (2017) Management strategies in Lynch syndrome and familial adenomatous polyposis: a national healthcare survey in Japan. Cancer Sci 108:243\u2013249. https:\/\/doi.org\/10.1111\/cas.13123","journal-title":"Cancer Sci"},{"key":"2892_CR174","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/bjs.5425","volume":"93","author":"AR Latchford","year":"2006","unstructured":"Latchford AR, Sturt NJ, Neale K et al (2006) A 10-year review of surgery for desmoid disease associated with familial adenomatous polyposis. Br J Surg 93:1258\u20131264. https:\/\/doi.org\/10.1002\/bjs.5425","journal-title":"Br J Surg"},{"key":"2892_CR175","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0002-9610(86)90147-9","volume":"152","author":"JK Stevenson","year":"1986","unstructured":"Stevenson JK, Reid BJ (1986) Unfamiliar aspects of familial polyposis coli. Am J Surg 152:81\u201386","journal-title":"Am J Surg"},{"key":"2892_CR176","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/MCG.0b013e3180325252","volume":"41","author":"L Benoit","year":"2007","unstructured":"Benoit L, Faivre L, Cheynel N et al (2007) 3\u02bc mutation of the APC gene and family history of FAP in a patient with apparently sporadic desmoid tumors. J Clin Gastroenterol 41:297\u2013300","journal-title":"J Clin Gastroenterol"},{"key":"2892_CR177","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1177\/2050640616678150","volume":"5","author":"T Walter","year":"2017","unstructured":"Walter T, Zhenzhen Wang C, Guillaud O et al (2017) Management of desmoid tumours: a large national database of familial adenomatous patients shows a link to colectomy modalities and low efficacy of medical treatments. United Eur Gastroenterol J 5:735\u2013741. https:\/\/doi.org\/10.1177\/2050640616678150","journal-title":"United Eur Gastroenterol J"},{"key":"2892_CR178","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/1097-0215(20010320)95:2<102::AID-IJC1018>3.0.CO;2-8","volume":"95","author":"L Bertario","year":"2001","unstructured":"Bertario L, Russo A, Sala P et al (2001) Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer 95:102\u2013107. https:\/\/doi.org\/10.1002\/1097-0215(20010320)95:2%3c102::AID-IJC1018%3e3.0.CO;2-8","journal-title":"Int J Cancer"},{"key":"2892_CR179","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1097\/DCR.0b013e318227e4e8","volume":"54","author":"MH Nieuwenhuis","year":"2011","unstructured":"Nieuwenhuis MH, Lefevre JH, B\u00fclow S et al (2011) Family history, surgery, and APC mutation are risk factors for desmoid tumors in familial adenomatous polyposis: an international cohort study. Dis Colon Rectum 54:1229\u20131234","journal-title":"Dis Colon Rectum"},{"key":"2892_CR180","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/DCR.0000000000000316","volume":"58","author":"J Church","year":"2015","unstructured":"Church J, Xhaja X, LaGuardia L et al (2015) Desmoids and genotype in familial adenomatous polyposis. Dis Colon Rectum 58:444\u2013448","journal-title":"Dis Colon Rectum"},{"key":"2892_CR181","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s10350-008-9232-5","volume":"51","author":"J Church","year":"2008","unstructured":"Church J, Lynch C, Neary P et al (2008) A desmoid tumor-staging system separates patients with intra-abdominal, familial adenomatous polyposis-associated desmoid disease by behavior and prognosis. Dis Colon Rectum 51:897\u2013901","journal-title":"Dis Colon Rectum"},{"key":"2892_CR182","first-page":"45","volume":"20","author":"H Ishida","year":"2020","unstructured":"Ishida H, Chikatani K, Mori Y et al (2020) Diagnosis, treatment, and proposal of the new classification system for the severity of desmoid tumors associated with familial adenomatous polyposis. J Heredi Tumors 20:45\u201358","journal-title":"J Hered Tumors"},{"key":"2892_CR183","doi-asserted-by":"publisher","first-page":"38","DOI":"10.23922\/jarc.2022-074","volume":"7","author":"K Kumamoto","year":"2023","unstructured":"Kumamoto K, Ishida H, Tomita N (2023) Recent advances and current management for desmoid tumor associated with familial adenomatous polyposis. J Anus Rectum Colon 7:38\u201351. https:\/\/doi.org\/10.23922\/jarc.2022-074","journal-title":"J Anus Rectum Colon"},{"key":"2892_CR184","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejca.2019.11.013","volume":"127","author":"Desmoid Tumor Working G","year":"2020","unstructured":"Desmoid Tumor Working G (2020) The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients. Eur J Cancer 127:96\u2013107","journal-title":"Eur J Cancer"},{"key":"2892_CR185","doi-asserted-by":"publisher","first-page":"e388","DOI":"10.1111\/j.1463-1318.2011.02758.x","volume":"13","author":"D Bocale","year":"2011","unstructured":"Bocale D, Rotelli MT, Cavallini A et al (2011) Anti-oestrogen therapy in the treatment of desmoid tumours: a systematic review. Colorectal Dis 13:e388-395. https:\/\/doi.org\/10.1111\/j.1463-1318.2011.02758.x","journal-title":"Colorectal Dis"},{"key":"2892_CR186","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/pbc.24457","volume":"60","author":"SX Skapek","year":"2013","unstructured":"Skapek SX, Anderson JR, Hill DA et al (2013) Safety and efficacy of high\u2010dose tamoxifen and sulindac for desmoid tumor in children: Results of a Children\u2019s Oncology Group (COG) Phase II Study. Pediatr Blood Cancer 60:1108\u20131112. https:\/\/doi.org\/10.1002\/pbc.24457","journal-title":"Pediatr Blood Cancer"},{"key":"2892_CR187","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1158\/1078-0432.CCR-10-1177","volume":"16","author":"R Chugh","year":"2010","unstructured":"Chugh R, Wathen JK, Patel SR et al (2010) Sarcoma Alliance for Research through C: Efficacy of imatinib in aggressive fibromatosis: Results of a phase \u2161 multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial. Clin Cancer Res 16:4884\u20134891. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1177","journal-title":"Clin Cancer Res"},{"key":"2892_CR188","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1200\/JCO.2005.04.0717","volume":"24","author":"MC Heinrich","year":"2006","unstructured":"Heinrich MC, McArthur GA, Demetri GD et al (2006) Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol 24:1195\u20131203. https:\/\/doi.org\/10.1200\/JCO.2005.04.0717","journal-title":"J Clin Oncol"},{"key":"2892_CR189","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ejca.2017.02.001","volume":"76","author":"B Kasper","year":"2017","unstructured":"Kasper B, Gruenwald V, Reichardt P et al (2017) 2017) Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase \u2161 study of the German Interdisciplinary Sarcoma Group (GISG. Eur J Cancer 76:60\u201367","journal-title":"Eur J Cancer"},{"key":"2892_CR190","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/annonc\/mdq341","volume":"22","author":"N Penel","year":"2011","unstructured":"Penel N, Le Cesne A, Bui BN et al (2011) Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC\/French Sarcoma Group phase \u2161 trial with a long-term follow-up. Ann Oncol 22:452\u2013457","journal-title":"Ann Oncol"},{"key":"2892_CR191","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1056\/NEJMoa1805052","volume":"379","author":"MM Gounder","year":"2018","unstructured":"Gounder MM, Mahoney MR, Van Tine BA et al (2018) Sorafenib for advanced and refractory desmoid tumors. N Engl J Med 379:2417\u20132428","journal-title":"N Engl J Med"},{"key":"2892_CR192","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/S1470-2045(19)30276-1","volume":"20","author":"M Toulmonde","year":"2019","unstructured":"Toulmonde M, Pulido M, Ray-Coquard I et al (2019) Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study. Lancet Oncol 20:1263\u20131272","journal-title":"Lancet Oncol"},{"key":"2892_CR193","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12306-022-00738-x","volume":"107","author":"S Tsukamoto","year":"2023","unstructured":"Tsukamoto S, Takahama T, Mavrogenis AF et al (2023) Clinical outcomes of medical treatments for progressive desmoid tumors following active surveillance: a systematic review. Musculoskelet Surg 107:7\u201318","journal-title":"Musculoskelet Surg"},{"key":"2892_CR194","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/1097-0142(20010901)92:5<1259::AID-CNCR1446>3.0.CO;2-Y","volume":"92","author":"A Azzarelli","year":"2001","unstructured":"Azzarelli A, Gronchi A, Bertulli R et al (2001) Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer 92:1259\u20131264. https:\/\/doi.org\/10.1002\/1097-0142(20010901)92:5%3c1259::AID-CNCR1446%3e3.0.CO;2-Y","journal-title":"Cancer"},{"key":"2892_CR195","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1200\/JCO.2006.08.2966","volume":"25","author":"SX Skapek","year":"2007","unstructured":"Skapek SX, Ferguson WS, Granowetter L et al (2007) Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase \u2161 Trial. J Clin Oncol 25:501\u2013506","journal-title":"J Clin Oncol"},{"key":"2892_CR196","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1200\/JCO.2005.02.1923","volume":"24","author":"M Gega","year":"2006","unstructured":"Gega M, Yanagi H, Yoshikawa R et al (2006) Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. J Clin Oncol 24:102\u2013105. https:\/\/doi.org\/10.1200\/JCO.2005.02.1923","journal-title":"J Clin Oncol"},{"key":"2892_CR197","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2019-000604","volume":"5","author":"A Napolitano","year":"2020","unstructured":"Napolitano A, Provenzano S, Colombo C et al (2020) Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis. ESMO Open 5:e000604","journal-title":"ESMO Open"},{"key":"2892_CR198","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1046\/j.1365-2168.1999.01222.x","volume":"86","author":"SK Clark","year":"1999","unstructured":"Clark SK, Neale KF, Landgrebe JC et al (1999) Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 86:1185\u20131189","journal-title":"Br J Surg"},{"key":"2892_CR199","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.21873\/anticanres.11702","volume":"37","author":"ML de Marchis","year":"2017","unstructured":"de Marchis ML, Tonelli F, Quaresmini D et al (2017) Desmoid tumors in familial adenomatous polyposis. Anticancer Res 37:3357\u20133366","journal-title":"Anticancer Res"},{"key":"2892_CR200","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1245\/s10434-016-5159-6","volume":"23","author":"SM Burtenshaw","year":"2016","unstructured":"Burtenshaw SM, Cannell AJ, McAlister ED et al (2016) Toward observation as first-line management in abdominal desmoid tumors. Ann Surg Oncol 23:2212\u20132219","journal-title":"Ann Surg Oncol"},{"key":"2892_CR201","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10689-008-9207-7","volume":"8","author":"T Iwama","year":"2009","unstructured":"Iwama T, Kuwabara K, Ushiama M et al (2009) Identification of somatic APC mutations in recurrent desmoid tumors in a patient with familial adenomatous polyposis to determine actual recurrence of the original tumor or de novo occurrence. Fam Cancer 8:51\u201354","journal-title":"Fam Cancer"},{"key":"2892_CR202","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/sj.bjc.6605997","volume":"104","author":"MH Nieuwenhuis","year":"2011","unstructured":"Nieuwenhuis MH, Mathus-Vliegen EM, Baeten CG et al (2011) Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients. Br J Cancer 104:37\u201342. https:\/\/doi.org\/10.1038\/sj.bjc.6605997","journal-title":"Br J Cancer"},{"key":"2892_CR203","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1046\/j.1365-2168.2000.01400.x","volume":"87","author":"AJ Smith","year":"2000","unstructured":"Smith AJ, Lewis JJ, Merchant NB et al (2000) Surgical management of intra-abdominal desmoid tumours. Br J Surg 87:608\u2013613. https:\/\/doi.org\/10.1046\/j.1365-2168.2000.01400.x","journal-title":"Br J Surg"},{"key":"2892_CR204","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s00595-017-1500-3","volume":"47","author":"Y Inoue","year":"2017","unstructured":"Inoue Y, Ishida H, Ueno H et al (2017) The treatment of desmoid tumors associated with familial adenomatous polyposis: the results of a Japanese multicenter observational study. Surg Today 47:1259\u20131267","journal-title":"Surg Today"},{"key":"2892_CR205","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1007\/s10350-005-0018-8","volume":"48","author":"J Church","year":"2005","unstructured":"Church J, Berk T, Boman BM et al (2005) Staging intra-abdominal desmoid tumors in familial adenomatous polyposis: a search for a uniform approach to a troubling disease. Dis Colon Rectum 48:1528\u20131534","journal-title":"Dis Colon Rectum"},{"key":"2892_CR206","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10689-013-9668-1","volume":"13","author":"A Yamada","year":"2014","unstructured":"Yamada A, Watabe H, Iwama T et al (2014) The prevalence of small intestinal polyps in patients with familial adenomatous polyposis: a prospective capsule endoscopy study. Fam Cancer 13:23\u201328","journal-title":"Fam Cancer"},{"key":"2892_CR207","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/gutjnl-2019-319915","volume":"69","author":"KJ Monahan","year":"2020","unstructured":"Monahan KJ, Bradshaw N, Dolwani S et al (2020) Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)\/Association of Coloproctology of Great Britain and Ireland (ACPGBI\/United Kingdom Cancer Genetics Group (UKCGG). Gut 69:411\u2013444","journal-title":"Gut"},{"key":"2892_CR208","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/j.1572-0241.2005.41506.x","volume":"100","author":"CA Burke","year":"2005","unstructured":"Burke CA, Santisi J, Church J et al (2005) The utility of capsule endoscopy small bowel surveillance in patients with polyposis. Am J Gastroenterol 100:1498\u20131502","journal-title":"Am J Gastroenterol"},{"key":"2892_CR209","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5301\/tj.5000390","volume":"102","author":"D Cavallo","year":"2016","unstructured":"Cavallo D, Ballardini G, Ferrari A et al (2016) Wireless capsule endoscopy in adolescents with familial adenomatous polyposis. Tumori 102:40\u201344. https:\/\/doi.org\/10.5301\/tj.5000390","journal-title":"Tumori"},{"key":"2892_CR210","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.gie.2007.07.048","volume":"67","author":"G Iaquinto","year":"2008","unstructured":"Iaquinto G, Fornasarig M, Quaia M et al (2008) Capsule endoscopy is useful and safe for small-bowel surveillance in familial adenomatous polyposis. Gastrointest Endosc 67:61\u201367","journal-title":"Gastrointest Endosc"},{"key":"2892_CR211","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.gie.2016.04.045","volume":"85","author":"IK Araujo","year":"2017","unstructured":"Araujo IK, Pages M, Romero C et al (2017) Twelve-year asymptomatic retention of a colon capsule endoscope. Gastrointest Endosc 85:681\u2013682","journal-title":"Gastrointest Endosc"},{"key":"2892_CR212","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1572-0241.2005.40102.x","volume":"100","author":"K Schulmann","year":"2005","unstructured":"Schulmann K, Hollerbach S, Kraus K et al (2005) Feasibility and diagnostic utility of video capsule endoscopy for the detection of small bowel polyps in patients with hereditary polyposis syndromes. Am J Gastroenterol 100:27\u201337","journal-title":"Am J Gastroenterol"},{"key":"2892_CR213","first-page":"24","volume":"2022","author":"K Tanaka","year":"2022","unstructured":"Tanaka K, Sato Y, Ishikawa H et al (2022) Small intestinal involvement and genotype-phenotype correlation in familial adenomatous polyposis. Techn Innovat Gastrointest Endosc 2022:24\u201334","journal-title":"Techn Innovat Gastrointest Endosc"},{"key":"2892_CR214","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.gie.2022.08.042","volume":"97","author":"G Fukushi","year":"2023","unstructured":"Fukushi G, Yamada M, Kakugawa Y et al (2023) Genotype-phenotype correlation of small-intestinal polyps on small-bowel capsule endoscopy in familial adenomatous polyposis. Gastrointest Endosc 97:59-68.e7","journal-title":"Gastrointest Endosc"},{"key":"2892_CR215","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/DCR.0000000000001008","volume":"61","author":"JS Shiroky","year":"2018","unstructured":"Shiroky JS, Lerner-Ellis JP, Govindarajan A et al (2018) Characteristics of adrenal masses in familial adenomatous polyposis. Dis Colon Rectum 61:679\u2013685","journal-title":"Dis Colon Rectum"},{"key":"2892_CR216","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1007\/BF02236860","volume":"43","author":"TG Smith","year":"2000","unstructured":"Smith TG, Clark SK, Katz DE et al (2000) Adrenal masses are associated with familial adenomatous polyposis. Dis Colon Rectum 43:1739\u20131742","journal-title":"Dis Colon Rectum"},{"key":"2892_CR217","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/BF02050923","volume":"40","author":"P Marchesa","year":"1997","unstructured":"Marchesa P, Fazio VW, Church JM et al (1997) Adrenal masses in patients with familial adenomatous polyposis. Dis Colon Rectum 40:1023\u20131028","journal-title":"Dis Colon Rectum"},{"key":"2892_CR218","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/pbc.20698","volume":"47","author":"S Aretz","year":"2006","unstructured":"Aretz S, Koch A, Uhlhaas S et al (2006) Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations? Pediatr Blood Cancer 47:811\u2013818. https:\/\/doi.org\/10.1002\/pbc.20698","journal-title":"Pediatr Blood Cancer"},{"key":"2892_CR219","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27103","volume":"65","author":"AD Trobaugh-Lotrario","year":"2018","unstructured":"Trobaugh-Lotrario AD, L\u00f3pez-Terrada D, Li P et al (2018) Hepatoblastoma in patients with molecularly proven familial adenomatous polyposis: Clinical characteristics and rationale for surveillance screening. Pediatr Blood Cancer 65:e27103","journal-title":"Pediatr Blood Cancer"},{"key":"2892_CR220","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/MPG.0000000000002247","volume":"68","author":"W Hyer","year":"2019","unstructured":"Hyer W, Cohen S, Attard T et al (2019) Management of familial adenomatous polyposis in children and adolescents: Position paper from the ESPGHAN polyposis working group. J Pediatr Gastroenterol Nutr 68:428\u2013441","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2892_CR221","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00595-018-1710-3","volume":"49","author":"H Sada","year":"2019","unstructured":"Sada H, Hinoi T, Ueno H et al (2019) Prevalence of and risk factors for thyroid carcinoma in patients with familial adenomatous polyposis: results of a multicenter study in Japan and a systematic review. Surg Today 49:72\u201381. https:\/\/doi.org\/10.1007\/s00595-018-1710-3","journal-title":"Surg Today"},{"key":"2892_CR222","first-page":"745","volume":"56","author":"RL Bennett","year":"1995","unstructured":"Bennett RL, Steinhaus KA, Uhrich SB et al (1995) Recommendations for standardized human pedigree nomenclature. Pedigree Standardization Task Force of the National Society of Genetic Counselors. Am J Hum Genet 56:745\u2013752","journal-title":"Am J Hum Genet"},{"key":"2892_CR223","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s10897-008-9169-9","volume":"17","author":"RL Bennett","year":"2008","unstructured":"Bennett RL, French KS, Resta RG et al (2008) Standardized human pedigree nomenclature: update and assessment of the recommendations of the National Society of Genetic Counselors. J Genet Couns 17:424\u2013433. https:\/\/doi.org\/10.1007\/s10897-008-9169-9","journal-title":"J Genet Couns"},{"key":"2892_CR224","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1002\/jgc4.1621","volume":"31","author":"RL Bennett","year":"2022","unstructured":"Bennett RL, French KS, Resta RG et al (2022) Practice resource-focused revision: Standardized pedigree nomenclature update centered on sex and gender inclusivity: A practice resource of the National Society of Genetic Counselors. J Genet Couns 31:1238\u20131248. https:\/\/doi.org\/10.1002\/jgc4.1621","journal-title":"J Genet Couns"},{"key":"2892_CR225","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/MPG.0000000000002845","volume":"71","author":"CC Anele","year":"2020","unstructured":"Anele CC, Xiang J, Martin I et al (2020) Polyp progression in paediatric patients with familial adenomatous polyposis: A single-centre Experience. J Pediatr Gastroenterol Nutr 71:612\u2013616","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2892_CR226","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.gie.2018.05.021","volume":"88","author":"S Sarvepalli","year":"2018","unstructured":"Sarvepalli S, Burke CA, Monachese M et al (2018) Natural history of colonic polyposis in young patients with familial adenomatous polyposis. Gastrointest Endosc 88:726\u2013733","journal-title":"Gastrointest Endosc"},{"key":"2892_CR227","first-page":"125","volume":"60","author":"F Kakuta","year":"2018","unstructured":"Kakuta F, Hoshi Y, Abukawa D (2018) The efficacy and safety of polyethylene glycol plus ascorbic acid for bowel cleansing before colonoscopy in children. Gastroenterol Endosc 60:125\u2013131","journal-title":"Gastroenterol Endosc"},{"key":"2892_CR228","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0022-3476(05)80297-5","volume":"119","author":"FM Giardiello","year":"1991","unstructured":"Giardiello FM, Offerhaus GJ, Krush AJ et al (1991) Risk of hepatoblastoma in familial adenomatous polyposis. J Pediatr 119:766\u2013768","journal-title":"J Pediatr"},{"key":"2892_CR229","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ajg.2014.435","volume":"110","author":"S Syngal","year":"2015","unstructured":"Syngal S, Brand RE, Church JM et al (2015) American College of Gastroenterology: ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 110:223\u2013262","journal-title":"Am J Gastroenterol"},{"key":"2892_CR230","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/humu.1380030206","volume":"3","author":"ML Bisgaard","year":"1994","unstructured":"Bisgaard ML, Fenger K, B\u00fclow S et al (1994) Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat 3:121\u2013125","journal-title":"Hum Mutat"},{"key":"2892_CR231","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1007\/s12094-015-1439-z","volume":"17","author":"C Guill\u00e9n-Ponce","year":"2015","unstructured":"Guill\u00e9n-Ponce C, Serrano R, S\u00e1nchez-Heras AB et al (2015) Clinical guideline seom: hereditary colorectal cancer. Clin Transl Oncol 17:962\u2013971","journal-title":"Clin Transl Oncol"},{"key":"2892_CR232","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1200\/JCO.2014.58.1322","volume":"33","author":"EM Stoffel","year":"2015","unstructured":"Stoffel EM, Mangu PB, Gruber SB et al (2015) Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol 33:209\u2013217","journal-title":"J Clin Oncol"},{"key":"2892_CR233","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/DCR.0000000000000912","volume":"60","author":"D Herzig","year":"2017","unstructured":"Herzig D, Hardiman K, Weiser M et al (2017) The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the management of inherited polyposis syndromes. Dis Colon Rectum 60:881\u2013894","journal-title":"Dis Colon Rectum"},{"key":"2892_CR234","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1056\/NEJMoa012015","volume":"346","author":"FM Giardiello","year":"2022","unstructured":"Giardiello FM, Yang VW, Hylind LM et al (2022) Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med 346:1054\u20131059","journal-title":"N Engl J Med"},{"key":"2892_CR235","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1056\/NEJM199305063281805","volume":"328","author":"FM Giardiello","year":"1993","unstructured":"Giardiello FM, Hamilton SR, Krush AJ et al (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328:1313\u20131316","journal-title":"N Engl J Med"},{"key":"2892_CR236","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10689-022-00292-2","volume":"21","author":"TM Neuhann","year":"2022","unstructured":"Neuhann TM, Haub K, Steinke-Lange V et al (2022) Long-term chemoprevention in patients with adenomatous polyposis coli: an observational study. Fam Cancer 21:463\u2013472","journal-title":"Fam Cancer"},{"key":"2892_CR237","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1056\/NEJMoa1916063","volume":"383","author":"CA Burke","year":"2020","unstructured":"Burke CA, Dekker E, Lynch P et al (2020) Eflornithine plus sulindac for prevention of progression in familial adenomatous polyposis. N Engl J Med 383:1028\u20131039","journal-title":"N Engl J Med"},{"key":"2892_CR238","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/DCR.0000000000002095","volume":"65","author":"F Balaguer","year":"2022","unstructured":"Balaguer F, Stoffel EM, Burke CA et al (2022) Combination of sulindac and eflornithine delays the need for lower gastrointestinal surgery in patients with familial adenomatous polyposis: Post hoc analysis of a randomized clinical trial. Dis Colon Rectum 65:536\u2013545","journal-title":"Dis Colon Rectum"},{"key":"2892_CR239","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1001\/jamaoncol.2017.5431","volume":"4","author":"NJ Samadder","year":"2018","unstructured":"Samadder NJ, Kuwada SK, Boucher KM et al (2018) Association of sulindac and erlotinib vs placebo with colorectal neoplasia in familial adenomatous polyposis: Secondary analysis of a randomized clinical trial. JAMA Oncol 4:671\u2013677","journal-title":"JAMA Oncol"},{"key":"2892_CR240","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","volume":"342","author":"G Steinbach","year":"2000","unstructured":"Steinbach G, Lynch PM, Phillips RK et al (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946\u20131952","journal-title":"N Engl J Med"},{"key":"2892_CR241","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2147\/CEG.S121841","volume":"10","author":"CA Burke","year":"2017","unstructured":"Burke CA, Phillips R, Berger MF et al (2017) Children\u2019s International Polyposis (CHIP) study: a randomized, double-blind, placebo-controlled study of celecoxib in children with familial adenomatous polyposis. Clin Exp Gastroenterol 10:177\u2013185. https:\/\/doi.org\/10.2147\/CEG.S121841","journal-title":"Clin Exp Gastroenterol"},{"key":"2892_CR242","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1056\/NEJMoa050405","volume":"352","author":"SD Solomon","year":"2005","unstructured":"Solomon SD, McMurray JJ, Pfeffer MA et al (2005) Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 352:1071\u20131080","journal-title":"N Engl J Med"},{"key":"2892_CR243","first-page":"4756","volume":"9","author":"T Higuchi","year":"2003","unstructured":"Higuchi T, Iwama T, Yoshinaga K et al (2003) A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients. Clin Cancer Res 9:4756\u20134760","journal-title":"Clin Cancer Res"},{"key":"2892_CR244","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10147-005-0548-z","volume":"11","author":"T Iwama","year":"2006","unstructured":"Iwama T, Akasu T, Utsunomiya J et al (2006) Does a selective cyclooxygenase-2 inhibitor (tiracoxib) induce clinically sufficient suppression of adenomas in patients with familial adenomatous polyposis? A randomized double-blind placebo-controlled clinical trial. Int J Clin Oncol 11:133\u2013139","journal-title":"Int J Clin Oncol"},{"key":"2892_CR245","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMoa050493","volume":"352","author":"RS Bresalier","year":"2005","unstructured":"Bresalier RS, Sandler RS, Quan H et al (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352:1092\u20131102","journal-title":"N Engl J Med"},{"key":"2892_CR246","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/gut.2009.200642","volume":"59","author":"NJ West","year":"2010","unstructured":"West NJ, Clark SK, Phillips RK et al (2010) Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis. Gut 59:918\u2013925 ([PMID: 20348368])","journal-title":"Gut"},{"key":"2892_CR247","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1016\/S0140-6736(18)31775-6","volume":"392","author":"MA Hull","year":"2018","unstructured":"Hull MA, Sprange K, Hepburn T et al (2018) Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2\u00d72 factorial trial. Lancet 392:2583\u20132594","journal-title":"Lancet"},{"key":"2892_CR248","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1158\/1940-6207.CAPR-11-0106","volume":"4","author":"J Burn","year":"2011","unstructured":"Burn J, Bishop DT, Chapman PD et al (2011) A randomized placebo-controlled prevention trial of aspirin and\/or resistant starch in young people with familial adenomatous polyposis. Cancer Prev Res (Phila) 4:655\u2013665","journal-title":"Cancer Prev Res (Phila)"},{"key":"2892_CR249","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/cam4.46","volume":"2","author":"H Ishikawa","year":"2013","unstructured":"Ishikawa H, Wakabayashi K, Suzuki S et al (2013) Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial. Cancer Med 2:50\u201356. https:\/\/doi.org\/10.1002\/cam4.46","journal-title":"Cancer Med"},{"key":"2892_CR250","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S2468-1253(21)00018-2","volume":"6","author":"H Ishikawa","year":"2021","unstructured":"Ishikawa H, Mutoh M, Sato Y et al (2021) Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study \u2163): a multicentre, double-blind, randomised, two-by-two factorial design trial. Lancet Gastroenterol Hepatol 6:474\u2013481","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2892_CR251","doi-asserted-by":"publisher","first-page":"19137","DOI":"10.1002\/cam4.6488","volume":"12","author":"E Saito","year":"2023","unstructured":"Saito E, Mutoh M, Ishikawa H et al (2023) Cost-effectiveness of preventive aspirin use and intensive downstaging polypectomy in patients with familial adenomatous polyposis: A microsimulation modeling study. Cancer Med 12:19137\u201319148. https:\/\/doi.org\/10.1002\/cam4.6488","journal-title":"Cancer Med"},{"key":"2892_CR252","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.25803","volume":"6","author":"GC Cloud","year":"2023","unstructured":"Cloud GC, Williamson JD, Thao LTP et al (2023) Low-dose aspirin and the risk of stroke and intracerebral bleeding in healthy older people: Secondary analysis of a randomized clinical trial. JAMA Netw Open 6:e2325803","journal-title":"JAMA Netw Open"},{"key":"2892_CR253","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/jmedgenet-2017-104545","volume":"55","author":"Z Ghorbanoghli","year":"2018","unstructured":"Ghorbanoghli Z, Bastiaansen BA, Langers AM et al (2018) Extracolonic cancer risk in Dutch patients with APC (adenomatous polyposis coli)-associated polyposis. J Med Genet 55:11\u201314","journal-title":"J Med Genet"},{"key":"2892_CR254","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/j.1463-1318.2011.02844.x","volume":"14","author":"S B\u00fclow","year":"2012","unstructured":"B\u00fclow S, Christensen IJ, H\u00f8jen H et al (2012) Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis. Colorectal Dis 14:947\u2013952","journal-title":"Colorectal Dis"},{"key":"2892_CR255","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10147-004-0414-4","volume":"9","author":"T Iwama","year":"2004","unstructured":"Iwama T, Tamura K, Morita T et al (2004) Japanese Society for Cancer of the Colon and Rectum: A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan. Int J Clin Oncol 9:308\u2013316. https:\/\/doi.org\/10.1007\/s10147-004-0414-4","journal-title":"Int J Clin Oncol"},{"key":"2892_CR256","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1111\/j.1572-0241.2000.02094.x","volume":"95","author":"T Matsumoto","year":"2000","unstructured":"Matsumoto T, Iida M, Nakamura S et al (2000) Natural history of ampullary adenoma in familial adenomatous polyposis: reconfirmation of benign nature during extended surveillance. Am J Gastroenterol 95:1557\u20131562","journal-title":"Am J Gastroenterol"},{"key":"2892_CR257","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11605-009-1091-4","volume":"14","author":"MD Johnson","year":"2010","unstructured":"Johnson MD, Mackey R, Brown N et al (2010) Outcome based on management for duodenal adenomas: sporadic versus familial disease. J Gastrointest Surg 14:229\u2013235. https:\/\/doi.org\/10.1007\/s11605-009-1091-4","journal-title":"J Gastrointest Surg"},{"key":"2892_CR258","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s10620-011-1917-2","volume":"57","author":"S Jaganmohan","year":"2012","unstructured":"Jaganmohan S, Lynch PM, Raju RP et al (2012) Endoscopic management of duodenal adenomas in familial adenomatous polyposis\u2013a single-center experience. Dig Dis Sci 57:732\u2013737","journal-title":"Dig Dis Sci"},{"key":"2892_CR259","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s10147-021-01881-4","volume":"26","author":"N Tomita","year":"2021","unstructured":"Tomita N, Ishida H, Tanakaya K et al (2021) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the clinical practice of hereditary colorectal cancer. Int J Clin Oncol 26:1353\u20131419","journal-title":"Int J Clin Oncol"},{"key":"2892_CR260","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/MCG.0000000000000555","volume":"51","author":"T Yachida","year":"2017","unstructured":"Yachida T, Nakajima T, Nonaka S et al (2017) Characteristics and clinical outcomes of duodenal neoplasia in Japanese patients with familial adenomatous polyposis. J Clin Gastroenterol 51:407\u2013411","journal-title":"J Clin Gastroenterol"},{"key":"2892_CR261","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1055\/a-1983-5963","volume":"55","author":"Y Takeuchi","year":"2023","unstructured":"Takeuchi Y, Hamada K, Nakahira H et al (2023) Efficacy and safety of intensive downstaging polypectomy (IDP) for multiple duodenal adenomas in patients with familial adenomatous polyposis: A prospective cohort study. Endoscopy 55:515\u2013523","journal-title":"Endoscopy"},{"key":"2892_CR262","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1055\/a-1189-9550","volume":"53","author":"M Sekiya","year":"2021","unstructured":"Sekiya M, Sakamoto H, Yano T et al (2021) Double-balloon endoscopy facilitates efficient endoscopic resection of duodenal and jejunal polyps in patients with familial adenomatous polyposis. Endoscopy 53:517\u2013521","journal-title":"Endoscopy"},{"key":"2892_CR263","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1007\/s00464-013-2996-2","volume":"27","author":"W Laleman","year":"2013","unstructured":"Laleman W, Verreth A, Topal B et al (2013) Endoscopic resection of ampullary lesions: a single-center 8-year retrospective cohort study of 91 patients with long-term follow-up. Surg Endosc 27:3865\u20133876","journal-title":"Surg Endosc"},{"key":"2892_CR264","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1007\/s10620-021-07132-w","volume":"67","author":"D Ramai","year":"2022","unstructured":"Ramai D, Facciorusso A, Singh J et al (2022) Endoscopic management of ampullary adenomas in familial adenomatous polyposis syndrome: A systematic review with pooled analysis. Dig Dis Sci 67:3220\u20133227","journal-title":"Dig Dis Sci"},{"key":"2892_CR265","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s00464-020-07433-7","volume":"35","author":"R Lee","year":"2021","unstructured":"Lee R, Huelsen A, Gupta S et al (2021) Endoscopic ampullectomy for non-invasive ampullary lesions: a single-center 10-year retrospective cohort study. Surg Endosc 35:684\u2013692. https:\/\/doi.org\/10.1007\/s00464-020-07433-7","journal-title":"Surg Endosc"},{"key":"2892_CR266","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10689-022-00288-y","volume":"21","author":"AS Aelvoet","year":"2022","unstructured":"Aelvoet AS, Struik D, Bastiaansen BAJ et al (2022) Colectomy and desmoid tumours in familial adenomatous polyposis: a systematic review and meta-analysis. Fam Cancer 21:429\u2013439 ([PMID: 35022961])","journal-title":"Fam Cancer"},{"key":"2892_CR267","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1210\/jc.2016-2043","volume":"101","author":"S Uchino","year":"2016","unstructured":"Uchino S, Ishikawa H, Miyauchi A et al (2016) Age- and gender-specific risk of thyroid cancer in patients with familial adenomatous polyposis. J Clin Endocrinol Metab 101:4611\u20134617. https:\/\/doi.org\/10.1210\/jc.2016-2043","journal-title":"J Clin Endocrinol Metab"},{"key":"2892_CR268","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10689-018-0097-z","volume":"18","author":"M Monachese","year":"2019","unstructured":"Monachese M, Mankaney G, Lopez R et al (2019) Outcome of thyroid ultrasound screening in FAP patients with a normal baseline exam. Fam Cancer 18:75\u201382. https:\/\/doi.org\/10.1007\/s10689-018-0097-z","journal-title":"Fam Cancer"},{"key":"2892_CR269","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/ng1342","volume":"36","author":"CM Suter","year":"2004","unstructured":"Suter CM, Martin DI, Ward RL (2004) Germline epimutation of MLH1 in individuals with multiple cancers. Nat Genet 36:497\u2013501. https:\/\/doi.org\/10.1038\/ng1342","journal-title":"Nat Genet"},{"key":"2892_CR270","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1056\/NEJMoa043146","volume":"352","author":"H Hampel","year":"2005","unstructured":"Hampel H, Frankel WL, Martin E et al (2005) Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352:1851\u20131860","journal-title":"N Engl J Med"},{"key":"2892_CR271","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/hmg\/6.1.105","volume":"6","author":"MG Dunlop","year":"1997","unstructured":"Dunlop MG, Farrington SM, Carothers AD et al (1997) Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 6:105\u2013110. https:\/\/doi.org\/10.1093\/hmg\/6.1.105","journal-title":"Hum Mol Genet"},{"key":"2892_CR272","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1399-0004.2008.01035.x","volume":"74","author":"E Barrow","year":"2008","unstructured":"Barrow E, Alduaij W, Robinson L et al (2008) Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations. Clin Genet 74:233\u2013242. https:\/\/doi.org\/10.1111\/j.1399-0004.2008.01035.x","journal-title":"Clin Genet"},{"key":"2892_CR273","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.bpg.2009.02.006","volume":"23","author":"S Grover","year":"2009","unstructured":"Grover S, Syngal S (2009) Genetic testing in gastroenterology: Lynch syndrome. Best Pract Res Clin Gastroenterol 23:185\u2013196. https:\/\/doi.org\/10.1016\/j.bpg.2009.02.006","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2892_CR274","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1365-2133.2007.08233.x","volume":"158","author":"K Yanaba","year":"2008","unstructured":"Yanaba K, Nakagawa H, Takeda Y et al (2008) Muir-Torre syndrome caused by partial duplication of MSH2 gene by Alu-mediated nonhomologous recombination. Br J Dermatol 158:150\u2013156. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08233.x","journal-title":"Br J Dermatol"},{"key":"2892_CR275","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1200\/JCO.2011.39.55","volume":"30","author":"AK Win","year":"2012","unstructured":"Win AK, Young JP, Lindor NM et al (2012) Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol 30:958\u2013964. https:\/\/doi.org\/10.1200\/JCO.2011.39.55","journal-title":"J Clin Oncol"},{"key":"2892_CR276","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1200\/JCO.2012.44.1238","volume":"31","author":"VM Raymond","year":"2013","unstructured":"Raymond VM, Mukherjee B, Wang F et al (2013) Elevated risk of prostate cancer among men with Lynch syndrome. J Clin Oncol 31:1713\u20131718. https:\/\/doi.org\/10.1200\/JCO.2012.44.1238","journal-title":"J Clin Oncol"},{"key":"2892_CR277","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1053\/j.gastro.2009.07.039","volume":"137","author":"E Stoffel","year":"2009","unstructured":"Stoffel E, Mukherjee B, Raymond VM et al (2009) Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology 137:1621\u20131627","journal-title":"Gastroenterology"},{"key":"2892_CR278","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1399-0004.2008.01125.x","volume":"75","author":"E Barrow","year":"2009","unstructured":"Barrow E, Robinson L, Alduaij W et al (2009) Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clin Genet 75:141\u2013149. https:\/\/doi.org\/10.1111\/j.1399-0004.2008.01125.x","journal-title":"Clin Genet"},{"key":"2892_CR279","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.gastro.2005.05.011","volume":"129","author":"H Hampel","year":"2005","unstructured":"Hampel H, Stephens JA, Pukkala E et al (2005) Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 129:415\u2013421","journal-title":"Gastroenterology"},{"key":"2892_CR280","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ijc.23508","volume":"123","author":"P Watson","year":"2008","unstructured":"Watson P, Vasen HFA, Mecklin JP et al (2008) The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer 123:444\u2013449. https:\/\/doi.org\/10.1002\/ijc.23508","journal-title":"Int J Cancer"},{"key":"2892_CR281","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","volume":"81","author":"M Aarnio","year":"1999","unstructured":"Aarnio M, Sankila R, Pukkala E et al (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81:214\u2013218","journal-title":"Int J Cancer"},{"key":"2892_CR282","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1001\/jama.2009.1529","volume":"302","author":"F Kastrinos","year":"2009","unstructured":"Kastrinos F, Mukherjee B, Tayob N et al (2009) Risk of pancreatic cancer in families with Lynch syndrome. JAMA 302:1790\u20131795","journal-title":"JAMA"},{"key":"2892_CR283","unstructured":"Kohlmann W, Gruber SB (2004) Lynch Syndrome. GeneReviews\u00ae. Seattle: University of Washington, 1993\u20132019."},{"key":"2892_CR284","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1470-2045(10)70265-5","volume":"12","author":"MJ Kempers","year":"2011","unstructured":"Kempers MJ, Kuiper RP, Ockeloen CW et al (2011) Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol 12:49\u201355","journal-title":"Lancet Oncol"},{"key":"2892_CR285","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1897-4287-11-9","volume":"11","author":"K Tutlewska","year":"2013","unstructured":"Tutlewska K, Lubinski J, Kurzawski G (2013) Germline deletions in the EPCAM gene as a cause of Lynch syndrome - literature review. Hered Cancer Clin Pract 11:9","journal-title":"Hered Cancer Clin Pract"},{"key":"2892_CR286","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/humu.21446","volume":"32","author":"RP Kuiper","year":"2011","unstructured":"Kuiper RP, Vissers LE, Venkatachalam R et al (2011) Recurrence and variability of germline EPCAM deletions in Lynch syndrome. Hum Mutat 32:407\u2013414. https:\/\/doi.org\/10.1002\/humu.21446","journal-title":"Hum Mutat"},{"key":"2892_CR287","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1158\/1055-9965.EPI-16-0693","volume":"26","author":"AK Win","year":"2017","unstructured":"Win AK, Jenkins MA, Dowty JG et al (2017) Prevalence and penetrance of major genes and polygenes for colorectal cancer. Cancer Epidemiol Biomarkers Prev 26:404\u2013412","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2892_CR288","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1200\/PO.20.00290","volume":"1","author":"RE Rosenblum","year":"2020","unstructured":"Rosenblum RE, Ang C, Suckiel SA et al (2020) Lynch syndrome-associated variants and cancer rates in an ancestrally diverse biobank. JCO Precis Oncol 1:1429\u20131444","journal-title":"JCO Precis Oncol"},{"key":"2892_CR289","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.3959","volume":"3","author":"AP Patel","year":"2020","unstructured":"Patel AP, Wang M, Fahed AC et al (2020) Association of rare pathogenic DNA variants for familial hypercholesterolemia, hereditary breast and ovarian cancer syndrome, and Lynch syndrome with disease risk in adults according to family history. JAMA Netw Open 3:e203959","journal-title":"JAMA Netw Open"},{"key":"2892_CR290","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1245\/s10434-011-2014-7","volume":"19","author":"G Canard","year":"2012","unstructured":"Canard G, Lefevre JH, Colas C et al (2012) Screening for Lynch syndrome in colorectal cancer: are we doing enough? Ann Surg Oncol 19:809\u2013816. https:\/\/doi.org\/10.1245\/s10434-011-2014-7","journal-title":"Ann Surg Oncol"},{"key":"2892_CR291","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1111\/j.1572-0241.2008.02084.x","volume":"103","author":"C Juli\u00e9","year":"2008","unstructured":"Juli\u00e9 C, Tr\u00e9sallet C, Brouquet A et al (2008) Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening. Am J Gastroenterol 103:2825\u20132835","journal-title":"Am J Gastroenterol"},{"key":"2892_CR292","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1016\/j.cgh.2020.12.007","volume":"20","author":"M Fujita","year":"2022","unstructured":"Fujita M, Liu X, Iwasaki Y et al (2022) Population-based screening for hereditary colorectal cancer variants in Japan. Clin Gastroenterol Hepatol 20:2132-2141.e9","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2892_CR293","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/jjco\/hyw178","volume":"47","author":"N Chika","year":"2017","unstructured":"Chika N, Eguchi H, Kumamoto K et al (2017) Prevalence of Lynch syndrome and Lynch-like syndrome among patients with colorectal cancer in a Japanese hospital-based population. Jpn J Clin Oncol 47:108\u2013117. https:\/\/doi.org\/10.1093\/jjco\/hyw178","journal-title":"Jpn J Clin Oncol"},{"key":"2892_CR294","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0016-5085(99)70510-X","volume":"116","author":"HF Vasen","year":"1999","unstructured":"Vasen HF, Watson P, Mecklin JP et al (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116:1453\u20131456","journal-title":"Gastroenterology"},{"key":"2892_CR295","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djh034","volume":"96","author":"A Umar","year":"2004","unstructured":"Umar A, Boland CR, Terdiman JP et al (2004) Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261\u2013268","journal-title":"J Natl Cancer Inst"},{"key":"2892_CR296","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1002\/ijc.33273","volume":"147","author":"H Blaker","year":"2020","unstructured":"Blaker H, Haupt S, Morak M et al (2020) Age-dependent performance of BRAF mutation testing in Lynch syndrome diagnostics. Int J Cancer 147:2801\u20132810. https:\/\/doi.org\/10.1002\/ijc.33273","journal-title":"Int J Cancer"},{"issue":"783\u2013813","key":"2892_CR297","volume":"149","author":"U Ladabaum","year":"2015","unstructured":"Ladabaum U, Ford JM, Martel M et al (2015) American Gastroenterological Association Technical Review on the diagnosis and management of Lynch syndrome. Gastroenterology 149(783\u2013813):e20","journal-title":"Gastroenterology"},{"key":"2892_CR298","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1001\/jama.2012.13088","volume":"308","author":"L Moreira","year":"2012","unstructured":"Moreira L, Balaguer F, Lindor N et al (2012) Identification of Lynch syndrome among patients with colorectal cancer. JAMA 308:1555\u20131565","journal-title":"JAMA"},{"key":"2892_CR299","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1002\/ijc.32044","volume":"144","author":"W Jiang","year":"2019","unstructured":"Jiang W, Cai MY, Li SY et al (2019) Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features. Int J Cancer 144:2161\u20132168","journal-title":"Int J Cancer"},{"key":"2892_CR300","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/jmg.2010.077677","volume":"47","author":"W Sjursen","year":"2010","unstructured":"Sjursen W, Haukanes BI, Grindedal EM et al (2010) Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers. J Med Genet 47:579\u2013585","journal-title":"J Med Genet"},{"key":"2892_CR301","first-page":"120","volume":"3","author":"Y Furukawa","year":"2010","unstructured":"Furukawa Y (2010) Review of hereditary colorectal cancer [HNPCC]\u2014current state in Japan. Front Colorectal Cancer 3:120\u2013124","journal-title":"Front Colorectal Cancer"},{"key":"2892_CR302","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1001\/jama.293.16.1986","volume":"293","author":"V Pi\u00f1ol","year":"2005","unstructured":"Pi\u00f1ol V, Castells A, Andreu M et al (2005) Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 293:1986\u20131894","journal-title":"JAMA"},{"key":"2892_CR304","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1053\/j.gastro.2007.04.044","volume":"133","author":"MA Jenkins","year":"2007","unstructured":"Jenkins MA, Hayashi S, O\u2019Shea AM et al (2007) Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology 133:48\u201356","journal-title":"Gastroenterology"},{"key":"2892_CR305","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/modpathol.2017.39","volume":"30","author":"S Sekine","year":"2017","unstructured":"Sekine S, Mori T, Ogawa R et al (2017) Mismatch repair deficiency commonly precedes adenoma formation in Lynch Syndrome-Associated colorectal tumorigenesis. Mod Pathol 30:1144\u20131151","journal-title":"Mod Pathol"},{"key":"2892_CR306","first-page":"1645","volume":"54","author":"LA Aaltonen","year":"1994","unstructured":"Aaltonen LA, Peltomaki P, Mecklin JP et al (1994) Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 54:1645\u20131648","journal-title":"Cancer Res"},{"key":"2892_CR307","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1056\/NEJM199805213382101","volume":"338","author":"LA Aaltonen","year":"1998","unstructured":"Aaltonen LA, Salovaara R, Kristo P et al (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338:1481\u20131487","journal-title":"N Engl J Med"},{"key":"2892_CR308","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1200\/JCO.2003.04.060","volume":"21","author":"P Peltom\u00e4ki","year":"2003","unstructured":"Peltom\u00e4ki P (2003) Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 21:1174\u20131179. https:\/\/doi.org\/10.1200\/JCO.2003.04.060","journal-title":"J Clin Oncol"},{"key":"2892_CR309","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.canlet.2004.07.017","volume":"216","author":"T Ishikubo","year":"2004","unstructured":"Ishikubo T, Nishimura Y, Yamaguchi K et al (2004) The clinical features of rectal cancers with high-frequency micro-satellite instability (MSI-H) in Japanese males. Cancer Lett 216:55\u201362. https:\/\/doi.org\/10.1016\/j.canlet.2004.07.017","journal-title":"Cancer Lett"},{"key":"2892_CR310","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/carcin\/bgp017","volume":"30","author":"S Asaka","year":"2009","unstructured":"Asaka S, Arai Y, Nishimura Y et al (2009) Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes\u02bc A to Dukes\u02bc B. Carcinogenesis 30:494\u2013499","journal-title":"Carcinogenesis"},{"key":"2892_CR311","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/his.14233","volume":"78","author":"MB Loughrey","year":"2021","unstructured":"Loughrey MB, McGrath J, Coleman HG et al (2021) Identifying mismatch repair-deficient colon cancer: near-perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population-based series. Histopathology 78:401\u2013413. https:\/\/doi.org\/10.1111\/his.14233","journal-title":"Histopathology"},{"key":"2892_CR312","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1097\/PAS.0b013e3181b15aa2","volume":"33","author":"J Shia","year":"2009","unstructured":"Shia J, Tang LH, Vakiani E et al (2009) Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. Am J Surg Pathol 33:1639\u20131645","journal-title":"Am J Surg Pathol"},{"key":"2892_CR313","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/modpathol.2012.138","volume":"26","author":"J Shia","year":"2013","unstructured":"Shia J, Zhang L, Shike M et al (2013) Secondary mutation in a coding mononucleotide tract in MSH6 causes loss of immunoexpression of MSH6 in colorectal carcinomas with MLH1\/PMS2 deficiency. Mod Pathol 26:131\u2013138","journal-title":"Mod Pathol"},{"key":"2892_CR314","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1002\/cncr.31534","volume":"124","author":"T Adar","year":"2018","unstructured":"Adar T, Rodgers LH, Shannon KM et al (2018) Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome. Cancer 124:3145\u20133153","journal-title":"Cancer"},{"key":"2892_CR315","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/gutjnl-2012-304356","volume":"62","author":"HF Vasen","year":"2013","unstructured":"Vasen HF, Blanco I, Aktan-Collan K et al (2013) Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 62:812\u2013823","journal-title":"Gut"},{"key":"2892_CR316","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1053\/j.gastro.2014.04.001","volume":"147","author":"FM Giardiello","year":"2014","unstructured":"Giardiello FM, Allen JI, Axilbund JE et al (2014) Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastroenterology 147:502\u2013526","journal-title":"Gastroenterology"},{"key":"2892_CR317","first-page":"808","volume":"57","author":"MF Kane","year":"1997","unstructured":"Kane MF, Loda M, Gaida GM et al (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57:808\u2013811","journal-title":"Cancer Res"},{"key":"2892_CR318","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/modpathol.2016.211","volume":"30","author":"T Adar","year":"2017","unstructured":"Adar T, Rodgers LH, Shannon KM et al (2017) A tailored approach to BRAF and MLH1 methylation testing in a universal screening program for Lynch syndrome. Mod Pathol 30:440\u2013447","journal-title":"Mod Pathol"},{"key":"2892_CR319","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ijc.29396","volume":"137","author":"I Spier","year":"2015","unstructured":"Spier I, Holzapfel S, Altmuller J et al (2015) Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas. Int J Cancer 137:320\u2013331. https:\/\/doi.org\/10.1002\/ijc.29396","journal-title":"Int J Cancer"},{"issue":"926\u2013932","key":"2892_CR320","first-page":"E1","volume":"144","author":"M Rodr\u00edguez-Soler","year":"2013","unstructured":"Rodr\u00edguez-Soler M, P\u00e9rez-Carbonell L, Guarinos C et al (2013) Risk of cancer in cases of suspected lynch syndrome without germline mutation. Gastroenterology 144(926\u2013932):E1","journal-title":"Gastroenterology"},{"key":"2892_CR321","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1053\/j.gastro.2014.01.041","volume":"146","author":"JM Carethers","year":"2014","unstructured":"Carethers JM (2014) Differentiating Lynch-like from Lynch syndrome. Gastroenterology 146:602\u2013604","journal-title":"Gastroenterology"},{"key":"2892_CR322","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/jmedgenet-2014-102284","volume":"51","author":"K Wimmer","year":"2014","unstructured":"Wimmer K, Kratz CP, Vasen HF et al (2014) Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium\u02bbcare for CMMRD (\u02bcC4CMMRD). J Med Genet 51:355\u2013365","journal-title":"J Med Genet"},{"key":"2892_CR323","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12876-021-01646-3","volume":"21","author":"K Hizuka","year":"2021","unstructured":"Hizuka K, Hagiwara SI, Maeyama T et al (2021) Constitutional mismatch repair deficiency in childhood colorectal cancer harboring a de novo variant in the MSH6 gene: a case report. BMC Gastroenterol 21:60. https:\/\/doi.org\/10.1186\/s12876-021-01646-3","journal-title":"BMC Gastroenterol"},{"key":"2892_CR324","unstructured":"Pediatric Chronic Specific Disease Information Center: PMS2 Deficiency. https:\/\/www.shouman.jp\/disease\/details\/10_02_016\/ (Accessed April 1, 2024)."},{"key":"2892_CR325","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1200\/JCO.20.02636","volume":"39","author":"C Durno","year":"2021","unstructured":"Durno C, Ercan AB, Bianchi V et al (2021) Survival benefit for individuals with constitutional mismatch repair deficiency undergoing surveillance. J Clin Oncol 39:2779\u20132790","journal-title":"J Clin Oncol"},{"key":"2892_CR326","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1053\/j.gastro.2017.02.011","volume":"152","author":"C Durno","year":"2017","unstructured":"Durno C, Boland CR, Cohen S et al (2017) Recommendations on surveillance and management of biallelic mismatch repair deficiency (BMMRD) syndrome: A consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastroenterology 152:1605\u20131614","journal-title":"Gastroenterology"},{"key":"2892_CR327","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/BF02053699","volume":"34","author":"HF Vasen","year":"1991","unstructured":"Vasen HF, Mecklin JP, Khan PM et al (1991) The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34:424\u2013425","journal-title":"Dis Colon Rectum"},{"key":"2892_CR328","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1001\/jama.293.16.1979","volume":"293","author":"NM Lindor","year":"2005","unstructured":"Lindor NM, Rabe K, Petersen GM et al (2005) Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293:1979\u20131985","journal-title":"JAMA"},{"key":"2892_CR329","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/jjco\/hyu190","volume":"45","author":"T Yamaguchi","year":"2015","unstructured":"Yamaguchi T, Furukawa Y, Nakamura Y et al (2015) Comparison of clinical features between suspected familial colorectal cancer type X and Lynch syndrome in Japanese patients with colorectal cancer: a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum. Jpn J Clin Oncol 45:153\u2013159","journal-title":"Jpn J Clin Oncol"},{"key":"2892_CR330","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/jjco\/hyab010","volume":"51","author":"H Hatamori","year":"2021","unstructured":"Hatamori H, Chino A, Arai M et al (2021) Malignant potential of colorectal neoplasms in Lynch syndrome: an analysis of 325 lesions endoscopically treated at a single institute. Jpn J Clin Oncol 51:737\u2013743","journal-title":"Jpn J Clin Oncol"},{"key":"2892_CR331","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/gut.33.6.783","volume":"33","author":"JR Jass","year":"1992","unstructured":"Jass JR, Stewart SM (1992) Evolution of hereditary non-polyposis colorectal cancer. Gut 33:783\u2013786","journal-title":"Gut"},{"key":"2892_CR332","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/00313029700169494","volume":"29","author":"JR Jass","year":"1997","unstructured":"Jass JR, Cottier DS, Pokos V et al (1997) Mixed epithelial polyps in association with hereditary non-polyposis colorectal cancer providing an alternative pathway of cancer histogenesis. Pathology 29:28\u201333","journal-title":"Pathology"},{"key":"2892_CR333","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ijc.31300","volume":"143","author":"A Ahadova","year":"2018","unstructured":"Ahadova A, Gallon R, Gebert J et al (2018) Three molecular pathways model colorectal carcinogenesis in Lynch syndrome. Int J Cancer 143:139\u2013150. https:\/\/doi.org\/10.1002\/ijc.31300","journal-title":"Int J Cancer"},{"key":"2892_CR334","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1001\/jamaoncol.2017.0619","volume":"3","author":"NAJ Ryan","year":"2017","unstructured":"Ryan NAJ, Morris J, Green K et al (2017) Association of mismatch repair mutation with age at cancer onset in Lynch syndrome: Implications for stratified surveillance strategies. JAMA Oncol 3:1702\u20131706","journal-title":"JAMA Oncol"},{"key":"2892_CR335","doi-asserted-by":"crossref","unstructured":"Sepp\u00e4l\u00e4 TT, Latchford A, Negoi I, et al. (2021) European guidelines from the EHTG and ESCP for Lynch syndrome an updated third edition of the Mallorca guidelines based on gene and gender. Br J Surg 108:484\u2013498.","DOI":"10.1002\/bjs.11902"},{"key":"2892_CR336","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0016-5085(00)70168-5","volume":"118","author":"HJ J\u00e4rvinen","year":"2000","unstructured":"J\u00e4rvinen HJ, Aarnio M, Mustonen H et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829\u2013834","journal-title":"Gastroenterology"},{"key":"2892_CR337","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cgh.2009.10.003","volume":"8","author":"C Engel","year":"2010","unstructured":"Engel C, Rahner N, Schulmann K et al (2010) Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer. Clin Gastroenterol Hepatol 8:174\u2013182","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2892_CR338","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1053\/j.gastro.2018.07.030","volume":"155","author":"C Engel","year":"2018","unstructured":"Engel C, Vasen HF, Sepp\u00e4l\u00e4 T et al (2018) No difference in colorectal cancer incidence or stage at detection by colonoscopy among 3 countries with different Lynch syndrome surveillance policies. Gastroenterology 155:1400-1409.e2","journal-title":"Gastroenterology"},{"key":"2892_CR339","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13053-019-0106-8","volume":"17","author":"TT Sepp\u00e4l\u00e4","year":"2019","unstructured":"Sepp\u00e4l\u00e4 TT, Ahadova A, Dominguez-Valentin M et al (2019) Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report. Hered Cancer Clin Pract 17:8","journal-title":"Hered Cancer Clin Pract"},{"key":"2892_CR340","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1186\/s13053-019-0106-8","volume":"158","author":"L Rivero-Sanchez","year":"2020","unstructured":"Rivero-Sanchez L, Arnau-Collell C, Herrero J et al (2020) White-light endoscopy is adequate for Lynch syndrome surveillance in a randomized and noninferiority study. Gastroenterology 158:895-904.e1. https:\/\/doi.org\/10.1186\/s13053-019-0106-8","journal-title":"Gastroenterology"},{"key":"2892_CR341","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1200\/JCO.2010.28.0453","volume":"28","author":"A Botma","year":"2010","unstructured":"Botma A, Nagengast FM, Braem MG et al (2010) Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: the GEOLynch cohort study. J Clin Oncol 28:4346\u20134353","journal-title":"J Clin Oncol"},{"key":"2892_CR342","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1200\/JCO.2014.58.9952","volume":"33","author":"M Movahedi","year":"2015","unstructured":"Movahedi M, Bishop DT, Macrae F et al (2015) Obesity, aspirin, and risk of colorectal cancer in carriers of hereditary colorectal cancer: A prospective investigation in the CAPP2 Study. J Clin Oncol 33:3591\u20133597","journal-title":"J Clin Oncol"},{"key":"2892_CR343","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","volume":"378","author":"J Burn","year":"2011","unstructured":"Burn J, Gerdes AM, Macrae F et al (2011) Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 378:2081\u20132087","journal-title":"Lancet"},{"key":"2892_CR344","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10689-013-9645-8","volume":"12","author":"FJ van Duijnhoven","year":"2013","unstructured":"van Duijnhoven FJ, Botma A, Winkels R et al (2013) Do lifestyle factors influence colorectal cancer risk in Lynch syndrome? Fam Cancer 12:285\u2013293","journal-title":"Fam Cancer"},{"key":"2892_CR345","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1053\/j.gastro.2011.10.033","volume":"142","author":"RM Winkels","year":"2012","unstructured":"Winkels RM, Botma A, Van Duijnhoven FJ et al (2012) Smoking increases the risk for colorectal adenomas in patients with Lynch syndrome. Gastroenterology 142:241\u2013247","journal-title":"Gastroenterology"},{"key":"2892_CR346","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/ije\/dyw036","volume":"45","author":"R Chau","year":"2016","unstructured":"Chau R, Dashti SG, Ait Ouakrim D et al (2016) Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome. Int J Epidemiol 45:940\u2013953","journal-title":"Int J Epidemiol"},{"key":"2892_CR347","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.cgh.2007.02.019","volume":"5","author":"B Diergaarde","year":"2007","unstructured":"Diergaarde B, Braam H, Vasen HF et al (2007) Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer. Clin Gastroenterol Hepatol 5:736\u2013742","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2892_CR348","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130018","volume":"10","author":"AB Kamiza","year":"2015","unstructured":"Kamiza AB, Hsieh LL, Tang R et al (2015) Risk factors associated with colorectal cancer in a subset of patients with mutations in MLH1 and MSH2 in Taiwan fulfilling the Amsterdam \u2161 criteria for Lynch syndrome. PLoS ONE 10:e0130018. https:\/\/doi.org\/10.1371\/journal.pone.0130018","journal-title":"PLoS ONE"},{"key":"2892_CR349","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1158\/1055-9965.EPI-16-0496","volume":"26","author":"SG Dashti","year":"2017","unstructured":"Dashti SG, Buchanan DD, Jayasekara H et al (2017) Alcohol consumption and the risk of colorectal cancer for mismatch repair gene mutation carriers. Cancer Epidemiol Biomarkers Prev 26:366\u2013375","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2892_CR350","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s00595-018-1654-7","volume":"48","author":"M Miguchi","year":"2018","unstructured":"Miguchi M, Hinoi T, Tanakaya K et al (2018) Alcohol consumption and early-onset risk of colorectal cancer in Japanese patients with Lynch syndrome: a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum. Surg Today 48:810\u2013814","journal-title":"Surg Today"},{"key":"2892_CR351","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1002\/ijc.31611","volume":"143","author":"SG Dashti","year":"2018","unstructured":"Dashti SG, Win AK, Hardikar SS et al (2018) Physical activity and the risk of colorectal cancer in Lynch syndrome. Int J Cancer 143:2250\u20132260. https:\/\/doi.org\/10.1002\/ijc.31611","journal-title":"Int J Cancer"},{"key":"2892_CR352","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s00384-013-1745-2","volume":"28","author":"JF Haanstra","year":"2013","unstructured":"Haanstra JF, Vasen HF, Sanduleanu S et al (2013) Quality colonoscopy and risk of interval cancer in Lynch syndrome. Int J Colorectal Dis 28:1643\u20131649","journal-title":"Int J Colorectal Dis"},{"key":"2892_CR353","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1136\/gutjnl-2016-311403","volume":"66","author":"P M\u00f8ller","year":"2017","unstructured":"M\u00f8ller P, Sepp\u00e4l\u00e4 T, Bernstein I et al (2017) Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database. Gut 66:1657\u20131664","journal-title":"Gut"},{"key":"2892_CR354","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/codi.13679","volume":"19","author":"CC Anele","year":"2017","unstructured":"Anele CC, Adegbola SO, Askari A et al (2017) Risk of metachronous colorectal cancer following colectomy in Lynch syndrome: a systematic review and meta-analysis. Colorectal Dis 19:528\u2013536","journal-title":"Colorectal Dis"},{"key":"2892_CR355","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10689-017-0062-2","volume":"17","author":"SS Malik","year":"2018","unstructured":"Malik SS, Lythgoe MP, McPhail M et al (2018) Metachronous colorectal cancer following segmental or extended colectomy in Lynch syndrome: a systematic review and meta-analysis. Fam Cancer 17:557\u2013564","journal-title":"Fam Cancer"},{"key":"2892_CR356","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1245\/s10434-012-2858-5","volume":"20","author":"AK Win","year":"2013","unstructured":"Win AK, Parry S, Parry B et al (2013) Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers. Ann Surg Oncol 20:1829\u20131836","journal-title":"Ann Surg Oncol"},{"key":"2892_CR357","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1159\/000481413","volume":"35","author":"T Nagasaki","year":"2018","unstructured":"Nagasaki T, Arai M, Chino A et al (2018) Feasibility of segmental colectomy followed by endoscopic surveillance as a treatment strategy for colorectal cancer patients with Lynch syndrome. Dig Surg 35:448\u2013456","journal-title":"Dig Surg"},{"key":"2892_CR358","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/jnci\/djr153","volume":"103","author":"FA Sinicrope","year":"2011","unstructured":"Sinicrope FA, Foster NR, Thibodeau SN et al (2011) DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy. J Natl Cancer Inst 103:863\u2013875","journal-title":"J Natl Cancer Inst"},{"key":"2892_CR359","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/j.ejca.2009.04.018","volume":"45","author":"G Des Guetz","year":"2009","unstructured":"Des Guetz G, Schischmanoff O, Nicolas P et al (2009) Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis. Eur J Cancer 45:1890\u20131896","journal-title":"Eur J Cancer"},{"key":"2892_CR360","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12885-015-1093-4","volume":"15","author":"EM Webber","year":"2015","unstructured":"Webber EM, Kauffman TL, O\u2019Connor E et al (2015) Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy. BMC Cancer 15:156","journal-title":"BMC Cancer"},{"key":"2892_CR361","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1200\/JCO.2015.63.4238","volume":"33","author":"T Andre","year":"2015","unstructured":"Andre T, de Gramont A, Vernerey D et al (2015) Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage \u2161 to \u2162 colon cancer: Updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study. J Clin Oncol 33:4176\u20134187","journal-title":"J Clin Oncol"},{"key":"2892_CR362","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1200\/JCO.20.01600","volume":"39","author":"R Cohen","year":"2021","unstructured":"Cohen R, Taieb J, Fiskum J et al (2021) Microsatellite instability in patients with stage \u2162 colon cancer receiving fluoropyrimidine with or without oxaliplatin: An ACCENT pooled analysis of 12 adjuvant trials. J Clin Oncol 39:642\u2013651","journal-title":"J Clin Oncol"},{"key":"2892_CR363","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1002\/cncr.26086","volume":"117","author":"B Tran","year":"2011","unstructured":"Tran B, Kopetz S, Tie J et al (2011) Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer. Cancer 117:4623\u20134632","journal-title":"Cancer"},{"key":"2892_CR364","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1158\/1078-0432.CCR-14-0332","volume":"20","author":"S Venderbosch","year":"2014","unstructured":"Venderbosch S, Nagtegaal ID, Maughan TS et al (2014) Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies. Clin Cancer Res 20:5322\u20135330","journal-title":"Clin Cancer Res"},{"key":"2892_CR365","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le DT, Uram JN, Wang H et al (2015) PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med 372:2509\u20132520","journal-title":"N Engl J Med"},{"key":"2892_CR366","first-page":"e55","volume":"16","author":"A Romiti","year":"2017","unstructured":"Romiti A, Rulli E, Pilozzi E et al (2017) Exploring the prognostic role of microsatellite instability in patients with stage \u2161 colorectal cancer: A systematic review and meta-analysis. Clin Colorectal Cancer 16:e55\u2013e59","journal-title":"Clin Colorectal Cancer"},{"key":"2892_CR367","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejca.2023.02.016","volume":"186","author":"DT Le","year":"2023","unstructured":"Le DT, Diaz LA Jr, Kim TW et al (2023) Pembrolizumab for previously treated, microsatellite instability-high\/mismatch repair-deficient advanced colorectal cancer: final analysis of KEYNOTE-164. Eur J Cancer 186:185\u2013195","journal-title":"Eur J Cancer"},{"key":"2892_CR368","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.annonc.2022.05.519","volume":"33","author":"M Maio","year":"2022","unstructured":"Maio M, Ascierto PA, Manzyuk L et al (2022) Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase \u2161 KEYNOTE-158 study. Ann Oncol 33:929\u2013938","journal-title":"Ann Oncol"},{"key":"2892_CR369","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","volume":"18","author":"MJ Overman","year":"2017","unstructured":"Overman MJ, McDermott R, Leach JL et al (2017) Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol 18:1182\u20131191","journal-title":"Lancet Oncol"},{"key":"2892_CR370","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","volume":"36","author":"MJ Overman","year":"2018","unstructured":"Overman MJ, Lonardi S, Wong KYM et al (2018) Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol 36:773\u2013779","journal-title":"J Clin Oncol"},{"key":"2892_CR371","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","volume":"383","author":"T Andr\u00e9","year":"2020","unstructured":"Andr\u00e9 T, Shiu KK, Kim TW et al (2020) Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N Engl J Med 383:2207\u20132218","journal-title":"N Engl J Med"},{"key":"2892_CR372","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/CEJ.0000000000000711","volume":"31","author":"I Carnevali","year":"2022","unstructured":"Carnevali I, Sahnane N, Chiaravalli AM et al (2022) Strategies for Lynch syndrome identification in selected and unselected gynecological cancers. Eur J Cancer Prev 31:369\u2013376","journal-title":"Eur J Cancer Prev"},{"key":"2892_CR373","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/ijc.33763","volume":"150","author":"S Zhao","year":"2022","unstructured":"Zhao S, Chen L, Zang Y et al (2022) Endometrial cancer in Lynch syndrome. Int J Cancer 150:7\u201317","journal-title":"Int J Cancer"},{"key":"2892_CR374","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1038\/s41436-019-0536-8","volume":"21","author":"NAJ Ryan","year":"2019","unstructured":"Ryan NAJ, Glaire MA, Blake D et al (2019) The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis. Genet Med 21:2167\u20132180","journal-title":"Genet Med"},{"key":"2892_CR375","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/ijgc-2021-003132","volume":"32","author":"N Lim","year":"2022","unstructured":"Lim N, Hickey M, Young GP et al (2022) Screening and risk-reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic review. Int J Gynecol Cancer 32:646\u2013655","journal-title":"Int J Gynecol Cancer"},{"key":"2892_CR376","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ygyno.2015.11.032","volume":"140","author":"A Shikama","year":"2016","unstructured":"Shikama A, Minaguchi T, Matsumoto K et al (2016) Clinicopathologic implications of DNA mismatch repair status in endometrial carcinomas. Gynecol Oncol 140:226\u2013233","journal-title":"Gynecol Oncol"},{"key":"2892_CR377","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.3892\/or.2012.2008","volume":"28","author":"K Masuda","year":"2012","unstructured":"Masuda K, Banno K, Hirasawa A et al (2012) Relationship of lower uterine segment cancer with Lynch syndrome: a novel case with an hMLH1 germline mutation. Oncol Rep 28:1537\u20131543","journal-title":"Oncol Rep"},{"key":"2892_CR378","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.1200\/JCO.2008.18.6296","volume":"26","author":"SN Westin","year":"2008","unstructured":"Westin SN, Lacour RA, Urbauer DL et al (2008) Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome. J Clin Oncol 26:5965\u20135971","journal-title":"J Clin Oncol"},{"key":"2892_CR379","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.640018","volume":"11","author":"D Dong","year":"2021","unstructured":"Dong D, Lei H, Liu D et al (2021) POLE and mismatch repair status, checkpoint proteins and tumor-infiltrating lymphocytes in combination, and tumor differentiation: identify endometrial cancers for immunotherapy. Front Oncol 11:640018","journal-title":"Front Oncol"},{"key":"2892_CR380","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1111\/jog.15273","volume":"48","author":"X Ran","year":"2022","unstructured":"Ran X, Jing H, Li Z (2022) The clinical features and management of Lynch syndrome-associated ovarian cancer. J Obstet Gynaecol Res 48:1538\u20131545","journal-title":"J Obstet Gynaecol Res"},{"key":"2892_CR381","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2022.33.e67","volume":"33","author":"T Tanaka","year":"2022","unstructured":"Tanaka T, Takehara K, Yamashita N et al (2022) Frequency and clinical features of deficient mismatch repair in ovarian clear cell and endometrioid carcinoma. J Gynecol Oncol 33:e67","journal-title":"J Gynecol Oncol"},{"key":"2892_CR382","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2022.101790","volume":"58\u201359","author":"J Llach","year":"2022","unstructured":"Llach J, Pellise M, Monahan K (2022) Lynch syndrome; towards more personalized management? Best Pract Res Clin Gastroenterol 58\u201359:101790","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2892_CR383","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1056\/NEJMoa052627","volume":"354","author":"KM Schmeler","year":"2006","unstructured":"Schmeler KM, Lynch HT, Chen LM et al (2006) Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 354:261\u2013269","journal-title":"N Engl J Med"},{"key":"2892_CR384","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.3390\/jcm9072290","volume":"9","author":"M Dominguez-Valentin","year":"2020","unstructured":"Dominguez-Valentin M, Sepp\u00e4l\u00e4 TT, Engel C et al (2020) Risk-reducing gynecological surgery in Lynch syndrome: results of an international survey from the Prospective Lynch Syndrome Database. J Clin Med 9:2290. https:\/\/doi.org\/10.3390\/jcm9072290","journal-title":"J Clin Med"},{"key":"2892_CR385","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/GRF.0000000000000499","volume":"63","author":"CL Swanson","year":"2020","unstructured":"Swanson CL, Bakkum-Gamez JN (2020) Preventing ovarian cancer in high-risk women: One surgery at a time. Clin Obstet Gynecol 63:64\u201373","journal-title":"Clin Obstet Gynecol"},{"key":"2892_CR386","doi-asserted-by":"crossref","unstructured":"Manchanda R, Gaba F, Talaulikar V, et al. (2021) Risk-reducing salpingo-oophorectomy and the use of hormone replacement therapy below the age of natural menopause: Scientific Impact Paper No. 66 October 2021: BJOG 129:e16-e34.","DOI":"10.1111\/1471-0528.16896"},{"key":"2892_CR387","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ygyno.2013.10.033","volume":"132","author":"MP Lachiewicz","year":"2014","unstructured":"Lachiewicz MP, Kravochuck SE, O\u2019Malley MM et al (2014) Prevalence of occult gynecologic malignancy at the time of risk reducing and nonprophylactic surgery in patients with Lynch syndrome. Gynecol Oncol 132:434\u2013437","journal-title":"Gynecol Oncol"},{"key":"2892_CR388","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/PGP.0000000000000643","volume":"39","author":"FA Fedda","year":"2020","unstructured":"Fedda FA, Euscher ED, Ramalingam P et al (2020) Prophylactic risk-reducing hysterectomies and bilateral salpingo-oophorectomies in patients with Lynch syndrome: A clinicopathologic study of 29 cases and review of the literature. Int J Gynecol Pathol 39:313\u2013320","journal-title":"Int J Gynecol Pathol"},{"key":"2892_CR389","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ygyno.2018.11.027","volume":"152","author":"CC Sun","year":"2019","unstructured":"Sun CC, Meyer LA, Daniels MS et al (2019) Women\u02bcs preferences for cancer risk management strategies in Lynch syndrome. Gynecol Oncol 152:514\u2013521","journal-title":"Gynecol Oncol"},{"key":"2892_CR390","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/AOG.0b013e3181b6f4f9","volume":"115","author":"KM Schmeler","year":"2010","unstructured":"Schmeler KM, Daniels MS, Soliman PT et al (2010) Primary peritoneal cancer after bilateral salpingo-oophorectomy in two patients with Lynch syndrome. Obstet Gynecol 115:432\u2013434","journal-title":"Obstet Gynecol"},{"key":"2892_CR391","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.eururo.2008.08.008","volume":"54","author":"M Roupr\u00eat","year":"2008","unstructured":"Roupr\u00eat M, Yates DR, Comperat E et al (2008) Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum. Eur Urol 54:1226\u20131236","journal-title":"Eur Urol"},{"key":"2892_CR392","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10689-012-9573-z","volume":"12","author":"PJ Barrow","year":"2013","unstructured":"Barrow PJ, Ingham S, O\u2019Hara C et al (2013) The spectrum of urological malignancy in Lynch syndrome. Fam Cancer 12:57\u201363","journal-title":"Fam Cancer"},{"key":"2892_CR393","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/iju.13481","volume":"25","author":"S Urakami","year":"2018","unstructured":"Urakami S, Inoshita N, Oka S et al (2018) Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening. Int J Urol 25:151\u2013156","journal-title":"Int J Urol"},{"key":"2892_CR394","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.urology.2015.08.018","volume":"86","author":"P Joost","year":"2015","unstructured":"Joost P, Therkildsen C, Dominguez-Valentin M et al (2015) Urinary tract cancer in Lynch syndrome; increased risk in carriers of MSH2 mutations. Urology 86:1212\u20131217","journal-title":"Urology"},{"key":"2892_CR395","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/jnci\/djs351","volume":"104","author":"AK Win","year":"2012","unstructured":"Win AK, Lindor NM, Young JP et al (2012) Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome. J Natl Cancer Inst 104:1363\u20131372","journal-title":"J Natl Cancer Inst"},{"key":"2892_CR396","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.eururo.2012.07.047","volume":"63","author":"SC Skeldon","year":"2013","unstructured":"Skeldon SC, Semotiuk K, Aronson M et al (2013) Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. Eur Urol 63:379\u2013385","journal-title":"Eur Urol"},{"key":"2892_CR397","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3233\/BLC-180180","volume":"4","author":"D Huang","year":"2018","unstructured":"Huang D, Matin SF, Lawrentschuk N et al (2018) Systematic review: An update on the spectrum of urological malignancies in Lynch syndrome. Bladder Cancer 4:261\u2013268","journal-title":"Bladder Cancer"},{"key":"2892_CR398","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/humu.22262","volume":"34","author":"JG Dowty","year":"2013","unstructured":"Dowty JG, Win AK, Buchanan DD et al (2013) Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat 34:490\u2013497. https:\/\/doi.org\/10.1002\/humu.22262","journal-title":"Hum Mutat"},{"key":"2892_CR399","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1200\/JCO.2012.48.0988","volume":"31","author":"VM Raymond","year":"2013","unstructured":"Raymond VM, Everett JN, Furtado LV et al (2013) Adrenocortical carcinoma is a Lynch syndrome-associated cancer. J Clin Oncol 31:3012\u20133018","journal-title":"J Clin Oncol"},{"key":"2892_CR400","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/modpathol.2016.171","volume":"30","author":"HL Harper","year":"2017","unstructured":"Harper HL, McKenney JK, Heald B et al (2017) Upper tract urothelial carcinomas: frequency of association with mismatch repair protein loss and Lynch syndrome. Mod Pathol 30:146\u2013156","journal-title":"Mod Pathol"},{"key":"2892_CR401","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.juro.2017.08.002","volume":"199","author":"MJ Metcalfe","year":"2018","unstructured":"Metcalfe MJ, Petros FG, Rao P et al (2018) Universal point of care testing for Lynch syndrome in patients with upper tract urothelial carcinoma. J Urol 199:60\u201365","journal-title":"J Urol"},{"key":"2892_CR402","doi-asserted-by":"publisher","first-page":"60","DOI":"10.23922\/jarc.2019-002","volume":"3","author":"JY Kim","year":"2019","unstructured":"Kim JY, Byeon JS (2019) Genetic counseling and surveillance focused on Lynch syndrome. J Anus Rectum Colon 3:60\u201368","journal-title":"J Anus Rectum Colon"},{"key":"2892_CR485","doi-asserted-by":"crossref","unstructured":"Hubosky SG, Boman BM, Charles S et al  (2013) Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch\nSyndrome (hereditary nonpolyposis colorectal cancer syndrome). BJU Int 112:813\u2013819 [PMID: 23452166]","DOI":"10.1111\/bju.12008"},{"key":"2892_CR403","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1053\/j.gastro.2009.10.051","volume":"138","author":"L Capelle","year":"2010","unstructured":"Capelle L, van Grieken N, Lingsma H et al (2010) Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology 138:487\u2013492","journal-title":"Gastroenterology"},{"key":"2892_CR404","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10120-020-01113-0","volume":"24","author":"H Cho","year":"2021","unstructured":"Cho H, Yamada M, Sekine S et al (2021) Gastric cancer is highly prevalent in Lynch syndrome patients with atrophic gastritis. Gastric Cancer 24:283\u2013291","journal-title":"Gastric Cancer"},{"key":"2892_CR405","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/s10038-019-0674-5","volume":"64","author":"T Ikenoue","year":"2019","unstructured":"Ikenoue T, Arai M, Ishioka C et al (2019) Importance of gastric cancer for the diagnosis and surveillance of Japanese Lynch syndrome patients. J Hum Genet 64:1187\u20131194. https:\/\/doi.org\/10.1038\/s10038-019-0674-5","journal-title":"J Hum Genet"},{"key":"2892_CR406","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10689-013-9615-1","volume":"12","author":"E Barrow","year":"2013","unstructured":"Barrow E, Hill J, Evans DG (2013) Cancer risk in Lynch Syndrome. Fam Cancer 12:229\u2013240. https:\/\/doi.org\/10.1007\/s10689-013-9615-1","journal-title":"Fam Cancer"},{"key":"2892_CR407","first-page":"32","volume":"10","author":"M Arai","year":"2010","unstructured":"Arai M, Ogawa T, Chino A et al (2010) Incidence and pathological features of tumors on surveillance by colonoscopy and upper gastroduodenal endoscopy in patients with Lynch syndrome. J Fam Tumor 10:32\u201338","journal-title":"J Fam Tumor"},{"key":"2892_CR408","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.3390\/cancers13143505","volume":"13","author":"R Olivier","year":"2021","unstructured":"Olivier R, Randrian V, Tougeron D et al (2021) Endoscopy to diagnose and prevent digestive cancers in Lynch syndrome. Cancers (Basel) 13:3505","journal-title":"Cancers (Basel)"},{"key":"2892_CR409","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/s41586-022-04508-4","volume":"603","author":"K Shitara","year":"2022","unstructured":"Shitara K, Ajani JA, Moehler M et al (2022) Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer. Nature 603:942\u2013948. https:\/\/doi.org\/10.1038\/s41586-022-04508-4","journal-title":"Nature"},{"key":"2892_CR410","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1136\/gutjnl-2017-314057","volume":"67","author":"P M\u00f8ller","year":"2018","unstructured":"M\u00f8ller P, Sepp\u00e4l\u00e4 TT, Bernstein I et al (2018) Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database. Gut 67:1306\u20131316","journal-title":"Gut"},{"key":"2892_CR411","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1200\/JCO.18.01512","volume":"37","author":"T Abe","year":"2019","unstructured":"Abe T, Blackford AL, Tamura K et al (2019) Deleterious germline mutations are a risk factor for neoplastic progression among high-risk individuals undergoing pancreatic surveillance. J Clin Oncol 37:1070\u20131080","journal-title":"J Clin Oncol"},{"key":"2892_CR412","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","volume":"69","author":"M Goggins","year":"2020","unstructured":"Goggins M, Overbeek KA, Brand R et al (2020) Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut 69:7\u201317","journal-title":"Gut"},{"key":"2892_CR413","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.gie.2021.12.002","volume":"95","author":"AH Calderwood","year":"2022","unstructured":"Calderwood AH, Sawhney MS, Thosani NC et al (2022) American Society for Gastrointestinal Endoscopy guideline on screening for pancreatic cancer in individuals with genetic susceptibility: methodology and review of evidence. Gastrointest Endosc 95:827-854.e3","journal-title":"Gastrointest Endosc"},{"key":"2892_CR414","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1053\/j.gastro.2018.05.035","volume":"155","author":"MI Canto","year":"2018","unstructured":"Canto MI, Almario JA, Schulick RD et al (2018) Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance. Gastroenterology 155:740-751.e2","journal-title":"Gastroenterology"},{"key":"2892_CR415","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/GIM.0b013e31818fa2ff","volume":"11","author":"Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group","year":"2009","unstructured":"Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group (2009) Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 11:35\u201341","journal-title":"Genet Med"},{"key":"2892_CR416","doi-asserted-by":"publisher","first-page":"djv005","DOI":"10.1093\/jnci\/djv005","volume":"107","author":"A Barzi","year":"2015","unstructured":"Barzi A, Sadeghi S, Kattan MW et al (2015) Comparative effectiveness of screening strategies for Lynch syndrome. J Natl Cancer Inst 107:djv005. https:\/\/doi.org\/10.1093\/jnci\/djv005","journal-title":"J Natl Cancer Inst"},{"key":"2892_CR417","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1200\/JOP.2011.000535","volume":"18","author":"G Wang","year":"2012","unstructured":"Wang G, Kuppermann M, Kim B et al (2012) Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome. Am J Manag Care 18:e179\u2013e185. https:\/\/doi.org\/10.1200\/JOP.2011.000535","journal-title":"Am J Manag Care"},{"key":"2892_CR418","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/GIM.0b013e3181cd666c","volume":"12","author":"M Mvundura","year":"2010","unstructured":"Mvundura M, Grosse SD, Hampel H et al (2010) The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med 12:93\u2013104","journal-title":"Genet Med"},{"key":"2892_CR419","doi-asserted-by":"publisher","first-page":"69","DOI":"10.7326\/0003-4819-155-2-201107190-00002","volume":"155","author":"U Ladabaum","year":"2011","unstructured":"Ladabaum U, Wang G, Terdiman J et al (2011) Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med 155:69\u201379","journal-title":"Ann Intern Med"},{"key":"2892_CR420","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s10147-021-01968-y","volume":"26","author":"Y Nakayama","year":"2021","unstructured":"Nakayama Y, Iijima T, Inokuchi T et al (2021) Clinicopathological features of sporadic MSI colorectal cancer and Lynch syndrome: a single-center retrospective cohort study. Int J Clin Oncol 26:1881\u20131889","journal-title":"Int J Clin Oncol"},{"key":"2892_CR421","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1002\/cam4.2432","volume":"8","author":"Y Kiyozumi","year":"2019","unstructured":"Kiyozumi Y, Matsubayashi H, Horiuchi Y et al (2019) Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients. Cancer Med 8:5534\u20135543","journal-title":"Cancer Med"},{"key":"2892_CR422","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.gim.2022.01.014","volume":"24","author":"N Abu-Ghazaleh","year":"2022","unstructured":"Abu-Ghazaleh N, Kaushik V, Gorelik A et al (2022) Worldwide prevalence of Lynch syndrome in patients with colorectal cancer: Systematic review and meta-analysis. Genet Med 24:971\u2013985","journal-title":"Genet Med"},{"key":"2892_CR423","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7326\/M18-3316","volume":"171","author":"D Li","year":"2019","unstructured":"Li D, Hoodfar E, Jiang SF et al (2019) Comparison of universal versus age-restricted screening of colorectal tumors for Lynch syndrome using mismatch repair immunohistochemistry: A Cohort Study. Ann Intern Med 171:19\u201326","journal-title":"Ann Intern Med"},{"key":"2892_CR424","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1200\/JCO.2012.45.1674","volume":"31","author":"B Heald","year":"2013","unstructured":"Heald B, Plesec T, Liu X et al (2013) Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing Lynch syndrome in a large academic medical center. J Clin Oncol 31:1336\u20131340. https:\/\/doi.org\/10.1200\/JCO.2012.45.1674","journal-title":"J Clin Oncol"},{"key":"2892_CR425","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1200\/JCO.2023.41.4_suppl.30","volume":"41","author":"AF Rouba","year":"2023","unstructured":"Rouba AF, Matthew O, Harris K et al (2023) Analysis of concordance between microsatellite instability by next generation sequencing (NGS-MSI) and mismatch repair deficiency by immunohistochemistry (IHC-MMR) in > 28,000 colorectal tumors. J Clin Oncol 41:30\u201330","journal-title":"J Clin Oncol"},{"key":"2892_CR426","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1200\/JCO.2007.13.2795","volume":"26","author":"A Liljegren","year":"2008","unstructured":"Liljegren A, Barker G, Elliott F et al (2008) Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma\/carcinoma prevention programme 2. J Clin Oncol 26:3434\u20133439. https:\/\/doi.org\/10.1200\/JCO.2007.13.2795","journal-title":"J Clin Oncol"},{"key":"2892_CR427","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/ajg.2014.423","volume":"110","author":"G Rahmi","year":"2015","unstructured":"Rahmi G, Lecomte T, Malka D et al (2015) Impact of chromoscopy on adenoma detection in patients with Lynch syndrome: a prospective, multicenter, blinded, tandem colonoscopy study. Am J Gastroenterol 110:288\u2013298","journal-title":"Am J Gastroenterol"},{"key":"2892_CR428","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1136\/bmj.38606.794560.EB","volume":"331","author":"I Dove-Edwin","year":"2005","unstructured":"Dove-Edwin I, Sasieni P, Adams J et al (2005) Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ 331:1047","journal-title":"BMJ"},{"key":"2892_CR429","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1001\/jama.2011.743","volume":"305","author":"V Bonadona","year":"2011","unstructured":"Bonadona V, Bonaiti B, Olschwang S et al (2011) Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 305:2304\u20132310","journal-title":"JAMA"},{"key":"2892_CR430","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/jnci\/djp473","volume":"102","author":"L Baglietto","year":"2010","unstructured":"Baglietto L, Lindor NM, Dowty JG et al (2010) Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst 102:193\u2013201. https:\/\/doi.org\/10.1093\/jnci\/djp473","journal-title":"J Natl Cancer Inst"},{"key":"2892_CR431","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1038\/s41436-019-0577-z","volume":"21","author":"M Suerink","year":"2019","unstructured":"Suerink M, Rodr\u00edguez-Girondo M, van der Klift HM et al (2019) (2019) An alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndrome. Genet Med 21:2706\u20132712","journal-title":"Genet Med"},{"key":"2892_CR432","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1053\/j.gastro.2008.04.026","volume":"135","author":"L Senter","year":"2008","unstructured":"Senter L, Clendenning M, Sotamaa K et al (2008) The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 135:419\u2013428","journal-title":"Gastroenterology"},{"key":"2892_CR433","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1200\/JCO.2018.78.4777","volume":"36","author":"SW ten Broeke","year":"2018","unstructured":"ten Broeke SW, van der Klift HM, Tops CMJ et al (2018) Cancer risks for PMS2-associated Lynch syndrome. J Clin Oncol 36:2961\u20132968","journal-title":"J Clin Oncol"},{"key":"2892_CR434","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/S1470-2045(21)00189-3","volume":"22","author":"International Mismatch Repair Consortium","year":"2021","unstructured":"International Mismatch Repair Consortium (2021) Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study. Lancet Oncol 22:1014\u20131022","journal-title":"Lancet Oncol"},{"key":"2892_CR436","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10689-006-0008-6","volume":"5","author":"AE DeJong","year":"2006","unstructured":"DeJong AE, Nagengast FM, Kleibeuker JH et al (2006) What is the appropriate screening protocol in Lynch syndrome? Fam Cancer 5:373\u2013378","journal-title":"Fam Cancer"},{"key":"2892_CR437","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1053\/j.gastro.2004.03.068","volume":"127","author":"YMC Hendriks","year":"2004","unstructured":"Hendriks YMC, Wagner A, Morreau H et al (2004) Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 127:17\u201325","journal-title":"Gastroenterology"},{"key":"2892_CR438","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1136\/jmg.2004.024299","volume":"42","author":"F Quehenberger","year":"2005","unstructured":"Quehenberger F, Vasen HFA, Van Houwelingen HC (2005) Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet 42:491\u2013496","journal-title":"J Med Genet"},{"key":"2892_CR439","doi-asserted-by":"publisher","first-page":"7810","DOI":"10.1158\/0008-5472.CAN-06-1114","volume":"66","author":"H Hampel","year":"2006","unstructured":"Hampel H, Frankel W, Panescu J et al (2006) Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 66:7810\u20137817","journal-title":"Cancer Res"},{"key":"2892_CR440","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.cgh.2006.01.002","volume":"4","author":"MA Jenkins","year":"2006","unstructured":"Jenkins MA, Baglietto L, Dowty JG et al (2006) Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study. Clin Gastroenterol Hepatol 4:489\u2013498","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2892_CR441","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/gut.2009.179804","volume":"59","author":"SR Cairns","year":"2010","unstructured":"Cairns SR, Scholefield JH, Steele RJ et al (2010) Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 59:666\u2013689","journal-title":"Gut"},{"key":"2892_CR442","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1053\/j.gastro.2015.07.036","volume":"149","author":"JH Rubenstein","year":"2015","unstructured":"Rubenstein JH, Enns R, Heidelbaugh J et al (2015) American Gastroenterological Association Institute Guideline on the diagnosis and management of Lynch syndrome. Gastroenterology 149:777\u2013782","journal-title":"Gastroenterology"},{"key":"2892_CR443","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1200\/JCO.2014.55.8536","volume":"33","author":"MA Jenkins","year":"2015","unstructured":"Jenkins MA, Dowty JG, Ait Ouakrim D et al (2015) Short-term risk of colorectal cancer in individuals with Lynch syndrome: a meta-analysis. J Clin Oncol 33:326\u2013331. https:\/\/doi.org\/10.1200\/JCO.2014.55.8536","journal-title":"J Clin Oncol"},{"key":"2892_CR444","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1200\/JCO.2014.57.8088","volume":"33","author":"SW ten Broeke","year":"2015","unstructured":"ten Broeke SW, Brohet RM, Tops CM et al (2015) Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk. J Clin Oncol 33:319\u2013325. https:\/\/doi.org\/10.1200\/JCO.2014.57.8088","journal-title":"J Clin Oncol"},{"key":"2892_CR445","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1053\/j.gastro.2021.04.010","volume":"161","author":"F Kastrinos","year":"2021","unstructured":"Kastrinos F, Ingram MA, Silver ER et al (2021) Gene-specific variation in colorectal cancer surveillance strategies for Lynch syndrome. Gastroenterology 161:453-462.e15","journal-title":"Gastroenterology"},{"key":"2892_CR446","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.gim.2022.05.016","volume":"24","author":"YJ Kang","year":"2022","unstructured":"Kang YJ, Caruana M, McLoughlin K et al (2022) The predicted effect and cost-effectiveness of tailoring colonoscopic surveillance according to mismatch repair gene in patients with Lynch syndrome. Genet Med 24:1831\u20131846","journal-title":"Genet Med"},{"key":"2892_CR447","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1053\/j.gastro.2010.02.053","volume":"138","author":"HF Vasen","year":"2010","unstructured":"Vasen HF, Abdirahman M, Brohet R et al (2010) One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroenterology 138:2300\u20132306","journal-title":"Gastroenterology"},{"key":"2892_CR448","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1056\/NEJMoa0801297","volume":"359","author":"J Burn","year":"2008","unstructured":"Burn J, Bishop DT, Mecklin JP et al (2008) Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med 359:2567\u20132578","journal-title":"N Engl J Med"},{"key":"2892_CR449","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/S0140-6736(20)30366-4","volume":"395","author":"J Burn","year":"2020","unstructured":"Burn J, Sheth H, Elliott F et al (2020) Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome, 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial. Lancet 395:1855\u20131863","journal-title":"Lancet"},{"key":"2892_CR450","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(18)31133-4","volume":"392","author":"PM Rothwell","year":"2018","unstructured":"Rothwell PM, Cook NR, Gaziano JM et al (2018) Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials. Lancet 392:387\u2013399","journal-title":"Lancet"},{"key":"2892_CR451","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1158\/1940-6207.CAPR-22-0044","volume":"15","author":"JC Mathers","year":"2022","unstructured":"Mathers JC, Elliott F, Macrae F et al (2022) Cancer prevention with resistant starch in Lynch syndrome patients in the CAPP2-randomized placebo controlled trial: Planned 10-year follow-up. Cancer Prev Res (Phila) 15:623\u2013634","journal-title":"Cancer Prev Res (Phila)"},{"key":"2892_CR452","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ygyno.2015.07.016","volume":"138","author":"G Tzortzatos","year":"2015","unstructured":"Tzortzatos G, Andersson E, Soller M et al (2015) The gynecological surveillance of women with Lynch syndrome in Sweden. Gynecol Oncol 138:717\u2013722","journal-title":"Gynecol Oncol"},{"key":"2892_CR453","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41436-020-01029-1","volume":"23","author":"M Dominguez-Valentin","year":"2021","unstructured":"Dominguez-Valentin M, Crosbie EJ, Engel C et al (2021) Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report. Genet Med 23:705\u2013712","journal-title":"Genet Med"},{"key":"2892_CR454","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1200\/JCO.2009.23.7784","volume":"27","author":"HJ J\u00e4rvinen","year":"2009","unstructured":"J\u00e4rvinen HJ, Renkonen-Sinisalo L, Akt\u00e1n-Coll\u00e1n K et al (2009) Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol 27:4793\u20134797","journal-title":"J Clin Oncol"},{"key":"2892_CR455","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/cncr.23554","volume":"113","author":"JS Kwon","year":"2008","unstructured":"Kwon JS, Sun CC, Peterson SK et al (2008) Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome. Cancer 113:326\u2013335","journal-title":"Cancer"},{"key":"2892_CR456","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10689-011-9444-z","volume":"10","author":"KY Yang","year":"2011","unstructured":"Yang KY, Caughey AB, Little SE et al (2011) A cost-effectiveness analysis of prophylactic surgery versus gynecologic surveillance for women from hereditary non-polyposis colorectal cancer (HNPCC) families. Fam Cancer 10:535\u2013543","journal-title":"Fam Cancer"},{"key":"2892_CR457","doi-asserted-by":"publisher","first-page":"6835","DOI":"10.1002\/cam4.4080","volume":"10","author":"M Alblas","year":"2021","unstructured":"Alblas M, Peterse EFP, Du M et al (2021) Cost-effectiveness of prophylactic hysterectomy in first-degree female relatives with Lynch syndrome of patients diagnosed with colorectal cancer in the United States: a microsimulation study. Cancer Med 10:6835\u20136844","journal-title":"Cancer Med"},{"key":"2892_CR458","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10689-014-9761-0","volume":"14","author":"R Moldovan","year":"2015","unstructured":"Moldovan R, Keating S (2015) Clancy T (1015) The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome. Fam Cancer 14:51\u201360","journal-title":"Fam Cancer"},{"key":"2892_CR459","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10689-017-9997-6","volume":"17","author":"H Etchegary","year":"2018","unstructured":"Etchegary H, Dicks E, Tamutis L et al (2018) Quality of life following prophylactic gynecological surgery: experiences of female Lynch mutation carriers. Fam Cancer 17:53\u201361","journal-title":"Fam Cancer"},{"key":"2892_CR460","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0140-6736(08)61159-9","volume":"372","author":"K Fukase","year":"2008","unstructured":"Fukase K, Kato M, Kikuchi S et al (2008) Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 372:392\u2013397","journal-title":"Lancet"},{"key":"2892_CR462","first-page":"2994","volume":"6","author":"YJ Park","year":"2000","unstructured":"Park YJ, Shin KH, Park JG (2000) Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea. Clin Cancer Res 6:2994\u20132998","journal-title":"Clin Cancer Res"},{"key":"2892_CR463","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1097\/MEG.0000000000002405","volume":"34","author":"R Ortig\u00e3o","year":"2022","unstructured":"Ortig\u00e3o R, Brito M, Pinto C et al (2022) Risk factors for gastric cancer in patients with Lynch syndrome. Eur J Gastroenterol Hepatol 34:912\u2013918","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2892_CR464","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00384-016-2524-7","volume":"31","author":"EC Soer","year":"2016","unstructured":"Soer EC, Leicher LW, Langers AM et al (2016) Equivalent Helicobacter pylori infection rates in Lynch syndrome mutation carriers with and without a first-degree relative with gastric cancer. Int J Colorectal Dis 31:693\u2013697. https:\/\/doi.org\/10.1007\/s00384-016-2524-7","journal-title":"Int J Colorectal Dis"},{"key":"2892_CR465","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1158\/1940-6207.CAPR-20-0269","volume":"13","author":"S Kumar","year":"2020","unstructured":"Kumar S, Dudzik CM, Reed M et al (2020) Upper endoscopic surveillance in Lynch syndrome detects gastric and duodenal adenocarcinomas. Cancer Prev Res (Phila) 13:1047\u20131054","journal-title":"Cancer Prev Res (Phila)"},{"key":"2892_CR466","doi-asserted-by":"publisher","first-page":"13","DOI":"10.14740\/gr1359","volume":"14","author":"D Saulino","year":"2021","unstructured":"Saulino D, Chen R, Wang K et al (2021) Characterization of chronic gastritis in Lynch syndrome patients with gastric adenocarcinoma. Gastroenterology Res 14:13\u201320","journal-title":"Gastroenterology Res"},{"key":"2892_CR467","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/jnci\/djp473","volume":"102","author":"L Baglietto","year":"2010","unstructured":"Baglietto L, Lindor NM, Dowty JG et al (2010) Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst 102:193\u2013201","journal-title":"J Natl Cancer Inst"},{"key":"2892_CR468","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1038\/s41436-019-0577-z","volume":"21","author":"M Suerink","year":"2019","unstructured":"Suerink M, Rodr\u00edguez-Girondo M, van der Klift HM et al (2019) An alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndrome. Genet Med 21:2706\u20132712","journal-title":"Genet Med"},{"key":"2892_CR469","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1053\/j.gastro.2008.04.026","volume":"135","author":"L Senter","year":"2008","unstructured":"Senter L, Clendenning M, Sotamaa K et al (2008) The clinical phenotype of Lynch syndrome due to germline PMS2 mutations. Gastroenterology 135:419\u2013428","journal-title":"Gastroenterology"},{"key":"2892_CR470","doi-asserted-by":"publisher","first-page":"14755","DOI":"10.1038\/ncomms14755","volume":"8","author":"S Haraldsdottir","year":"2017","unstructured":"Haraldsdottir S, Rafnar T, Frankel WL et al (2017) Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2. Nature Comm 8:14755","journal-title":"Nature Comm"},{"key":"2892_CR471","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13053-022-00241-1","volume":"20","author":"P M\u00f8ller","year":"2022","unstructured":"M\u00f8ller P, Sepp\u00e4l\u00e4 T, Dowty JG et al (2022) European Hereditary Tumour Group (EHTG) and the International Mismatch Repair Consortium (IMRC): Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective Lynch syndrome database and the international mismatch repair consortium. Hered Cancer Clin Pract 20:36. https:\/\/doi.org\/10.1186\/s13053-022-00241-1","journal-title":"Hered Cancer Clin Pract"},{"key":"2892_CR472","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1200\/JCO.2018.78.4777","volume":"36","author":"SW Ten Broeke","year":"2018","unstructured":"Ten Broeke SW, van der Klift HM, Tops CMJ et al (2018) Cancer risks for PMS2-associated Lynch syndrome. J Clin Oncol 36:2961\u20132968. https:\/\/doi.org\/10.1200\/JCO.2018.78.4777","journal-title":"J Clin Oncol"},{"key":"2892_CR473","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41436-019-0596-9","volume":"22","author":"M Dominguez-Valentin","year":"2020","unstructured":"Dominguez-Valentin M, Sampson J, Sepp\u00e4l\u00e4 T et al (2020) Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genet Med 22:15\u201325","journal-title":"Genet Med"},{"key":"2892_CR474","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101909","volume":"58","author":"M Dominguez-Valentin","year":"2023","unstructured":"Dominguez-Valentin M, Haupt S, Sepp\u00e4l\u00e4 TT et al (2023) Mortality by age, gene, and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database. EClinicalMedicine 58:101909","journal-title":"EClinicalMedicine"},{"key":"2892_CR476","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.21037\/jgo-22-165","volume":"13","author":"N Kanaya","year":"2022","unstructured":"Kanaya N, Aoki H, Morito T et al (2022) Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome. J Gastrointest Oncol 13:2532\u20133253","journal-title":"J Gastrointest Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02892-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-025-02892-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02892-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:02:29Z","timestamp":1767596549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-025-02892-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":473,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2892"],"URL":"https:\/\/doi.org\/10.1007\/s10147-025-02892-1","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All members with the exception of the discussion chair (committee chair) voted in all CQs. None of the committee members reported on economic COIs, determined according to the rules of the JSCCR. Also, none of the commissioners had academic COIs for CQs. Therefore, all of the committee members except the discussion chair voted in all CQs.As a result of the self-reported declarations of conflicts of interest (COI) by the members of the JSCCR HCRC Guideline Committee and the JSCCR Guideline Evaluation Committee, the following companies were disclosed:AstraZeneca K.K., Eisai Co., Ltd., Olympus Corporation, Asahi Kasei Pharma Corporation, Takeda Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd., Fuji Pharma Co., Ltd., Taiho pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd. and Amino Up Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}